<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">89281</article-id><article-id pub-id-type="doi">10.7554/eLife.89281</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.89281.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Deciphering the complex relationship between type 2 diabetes and fracture risk with both genetic and observational evidence</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-318917"><name><surname>Zhao</surname><given-names>Pianpian</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0009-1676-1748</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-318918"><name><surname>Sheng</surname><given-names>Zhifeng</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-314910"><name><surname>Xu</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-318919"><name><surname>Li</surname><given-names>Peng</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-318920"><name><surname>Xiao</surname><given-names>Wenjin</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-314903"><name><surname>Yuan</surname><given-names>Chengda</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-318921"><name><surname>Xu</surname><given-names>Zhanwei</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-318922"><name><surname>Yang</surname><given-names>Mengyuan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-314899"><name><surname>Qian</surname><given-names>Yu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-318923"><name><surname>Zhong</surname><given-names>Jiadong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-318924"><name><surname>Gu</surname><given-names>Jiaxuan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-147793"><name><surname>Karasik</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-153733"><name><surname>Zheng</surname><given-names>Hou-Feng</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5681-8598</contrib-id><email>zhenghoufeng@westlake.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05hfa4n20</institution-id><institution>The affiliated Hangzhou first people’s hospital, School of Medicine, Westlake University</institution></institution-wrap><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05hfa4n20</institution-id><institution>Diseases &amp; Population (DaP) Geninfo Lab, School of Life Sciences, Westlake University, Hangzhou, China</institution></institution-wrap><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution>Westlake Laboratory of Life Sciences and Biomedicine</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/055qbch41</institution-id><institution>Institute of Basic Medical Sciences, Westlake Institute for Advanced Study</institution></institution-wrap><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f1zfq44</institution-id><institution>Health Management Center, The Second Xiangya Hospital of Central South University</institution></institution-wrap><addr-line><named-content content-type="city">Changsha</named-content></addr-line><country>China</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/008w1vb37</institution-id><institution>Department of Orthopedics, Yantai Affiliated Hospital of Binzhou Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Yantai</named-content></addr-line><country>China</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02sysn258</institution-id><institution>Department of Geratology, The Third People's Hospital of Hangzhou</institution></institution-wrap><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02xjrkt08</institution-id><institution>Department of Endocrinology, Second Affiliated Hospital of Soochow University</institution></institution-wrap><addr-line><named-content content-type="city">Suzhou</named-content></addr-line><country>China</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03a8g0p38</institution-id><institution>Department of Dermatology, Hangzhou Hospital of Traditional Chinese Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff><aff id="aff10"><label>10</label><institution>Central Health Center of Mashenqiao Town</institution><addr-line><named-content content-type="city">Tianjin</named-content></addr-line><country>China</country></aff><aff id="aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03kgsv495</institution-id><institution>Azrieli Faculty of Medicine, Bar-Ilan University</institution></institution-wrap><addr-line><named-content content-type="city">Safed</named-content></addr-line><country>Israel</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Kim</surname><given-names>Se-Min</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Choi</surname><given-names>Murim</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04h9pn542</institution-id><institution>Seoul National University</institution></institution-wrap><country>Republic of Korea</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>09</day><month>04</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP89281</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-06-07"><day>07</day><month>06</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-06-29"><day>29</day><month>06</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.06.23.23291786"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-08-25"><day>25</day><month>08</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.89281.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-03-05"><day>05</day><month>03</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.89281.2"/></event></pub-history><permissions><copyright-statement>© 2023, Zhao, Sheng, Xu et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Zhao, Sheng, Xu et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-89281-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-89281-figures-v1.pdf"/><abstract><p>The ‘diabetic bone paradox’ suggested that type 2 diabetes (T2D) patients would have higher areal bone mineral density (BMD) but higher fracture risk than individuals without T2D. In this study, we found that the genetically predicted T2D was associated with higher BMD and lower risk of fracture in both weighted genetic risk score (wGRS) and two-sample Mendelian randomization (MR) analyses. We also identified ten genomic loci shared between T2D and fracture, with the top signal at SNP rs4580892 in the intron of gene <italic>RSPO3</italic>. And the higher expression in adipose subcutaneous and higher protein level in plasma of <italic>RSPO3</italic> were associated with increased risk of T2D, but decreased risk of fracture. In the prospective study, T2D was observed to be associated with higher risk of fracture, but BMI mediated 30.2% of the protective effect. However, when stratified by the T2D-related risk factors for fracture, we observed that the effect of T2D on the risk of fracture decreased when the number of T2D-related risk factors decreased, and the association became non-significant if the T2D patients carried none of the risk factors. In conclusion, the genetically determined T2D might not be associated with higher risk of fracture. And the shared genetic architecture between T2D and fracture suggested a top signal around <italic>RSPO3</italic> gene. The observed effect size of T2D on fracture risk decreased if the T2D-related risk factors could be eliminated. Therefore, it is important to manage the complications of T2D to prevent the risk of fracture.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>type 2 diabetes</kwd><kwd>fracture</kwd><kwd>Mendelian randomization analyses</kwd><kwd>observational analyses</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>The &quot;Pioneer&quot; and &quot;Leading Goose&quot; R&amp;D Program of Zhejiang</institution></institution-wrap></funding-source><award-id>2023C03164</award-id><principal-award-recipient><name><surname>Zheng</surname><given-names>Hou-Feng</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82370887</award-id><principal-award-recipient><name><surname>Zheng</surname><given-names>Hou-Feng</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>The Chinese National Key Technology R&amp;D Program, Ministry of Science and Technology</institution></institution-wrap></funding-source><award-id>2021YFC2501702</award-id><principal-award-recipient><name><surname>Zheng</surname><given-names>Hou-Feng</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>The &quot;Pioneer&quot; and &quot;Leading Goose&quot; R&amp;D Program of Zhejiang</institution></institution-wrap></funding-source><award-id>2024SSYS0032</award-id><principal-award-recipient><name><surname>Zheng</surname><given-names>Hou-Feng</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>The Westlake Laboratory of Life Sciences and Biomedicine</institution></institution-wrap></funding-source><award-id>202208014</award-id><principal-award-recipient><name><surname>Zheng</surname><given-names>Hou-Feng</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Genetically determined type 2 diabetes (T2D) may not increase the risk of fracture, but managing T2D-related risk factors is crucial to prevent fracture in patients with T2D.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Type 2 diabetes (T2D), a chronic metabolic disorder characterized by elevated blood glucose levels and increased risk of numerous serious and life-threatening complications, constitutes one of the biggest health problems in the world (<xref ref-type="bibr" rid="bib17">Diamond, 2003</xref>). According to Global Burden of Disease (GBD) data, the age-standardized global prevalence of type 2 diabetes was approximately 6.0% in men and 5.0% in women in 2019 (<xref ref-type="bibr" rid="bib51">Tinajero and Malik, 2021</xref>). It accounts for more than 100 billion dollars of healthcare costs annually in the United States (<xref ref-type="bibr" rid="bib17">Diamond, 2003</xref>). The chronic comorbidities of T2D could develop gradually, and could lead to serious damage to the heart, blood vessels, kidneys, eyes, and feet (<xref ref-type="bibr" rid="bib50">Teck, 2022</xref>). Other organ systems such as skeletal health could also be influenced by T2D (<xref ref-type="bibr" rid="bib27">Lei and Kindler, 2022</xref>).</p><p>Osteoporosis is a common musculoskeletal disease characterized by low bone mass and disruption of bone microarchitecture, leading to an increased risk of fracture. Our previous studies have suggested that bone mass and fracture could be influenced by many modifiable or non-modifiable factors (<xref ref-type="bibr" rid="bib61">Zhu and Zheng, 2021</xref>), such as body weight (<xref ref-type="bibr" rid="bib62">Zhu et al., 2022</xref>), sleep behavior (<xref ref-type="bibr" rid="bib39">Qian et al., 2021</xref>), inflammatory disease (<xref ref-type="bibr" rid="bib54">Xia et al., 2020</xref>), birth weight (<xref ref-type="bibr" rid="bib55">Xia et al., 2022</xref>), and genetic factors (<xref ref-type="bibr" rid="bib60">Zhu et al., 2021</xref>). T2D is also considered to be a major factor that could affect bone health, it seems that T2D patients would have higher BMD and higher fracture risk than individuals without T2D (<xref ref-type="bibr" rid="bib25">Khosla et al., 2021</xref>). This is the so-called ‘diabetic bone paradox’ (<xref ref-type="bibr" rid="bib10">Botella Martínez et al., 2016</xref>; <xref ref-type="bibr" rid="bib41">Romero-Díaz et al., 2021</xref>). For example, in an Italian nationwide study of 59,950 women of whom 5.2% had diabetes (predominantly type 2 diabetes), noted an association between diabetes and any fracture (OR 1.3, 95% CI 1.1–1.4, and OR 1.3, 95% CI 1.2–1.5, for vertebral or hip fractures and non-vertebral, non-hip fractures, respectively) (<xref ref-type="bibr" rid="bib1">Adami et al., 2020</xref>). Interestingly, the prevalence of vertebral or hip fracture was higher in participants with diabetes but without obesity (OR 1.9, 95% CI 1.7–2.1) than in patients with obesity and diabetes (OR 1.5, 95% CI 1.3–1.8), suggesting that obesity might be partially protective against vertebral or hip fractures in type 2 diabetes (<xref ref-type="bibr" rid="bib1">Adami et al., 2020</xref>).</p><p>However, a recent comparative cohort analysis using routinely collected UK primary care records data from the Health Improvement Network (including 174,244 individuals with incident type 2 diabetes and 747,290 without diabetes) found no evidence to suggest a higher risk of fracture in type 2 diabetes patients, specifically, the risk of having at least one fracture was estimated to be 6% lower for females and 3% lower for males in the type 2 diabetes cohort than for females and males without diabetes (<xref ref-type="bibr" rid="bib16">Davie et al., 2021</xref>). Lower fracture risk was also observed in the type 2 diabetes patients compared to those without the disease in the age group greater than 85 years (<xref ref-type="bibr" rid="bib16">Davie et al., 2021</xref>). Another large-scale cohort study showed that type 2 diabetes could only explain less than 0.1% of the fracture risk (<xref ref-type="bibr" rid="bib6">Axelsson et al., 2023</xref>), and if the T2D patients with risk factors (such as low BMI, long diabetes duration, insulin treatment, and low physical activity) were excluded, T2D patients would have lower fracture risk than their matched controls (<xref ref-type="bibr" rid="bib6">Axelsson et al., 2023</xref>). In a prospective study to examine the relationship between BMD and fracture in older adults with type 2 diabetes, it was reported that femoral neck BMD T score and FRAX score were both associated with fracture risk in individuals with type 2 diabetes, suggesting that BMD is still a useful clinical predictor for the evaluation of fracture risk in type 2 diabetes patients (<xref ref-type="bibr" rid="bib46">Schwartz et al., 2011</xref>).</p><p>As the pathophysiology of fracture is more complicated than the BMD trait, and while there were some explanations for the ‘diabetic bone paradox’ (<xref ref-type="bibr" rid="bib38">Osório, 2011</xref>), the integrated analyses with genetic data for the diseases could provide an alternative approach to alleviate the bias of the unknown confounding factors (<xref ref-type="bibr" rid="bib15">Davey Smith and Hemani, 2014</xref>). Therefore, in this study, we first performed a weighted genetic risk score (wGRS) regression analysis to assess the relationship between the genetically predicted T2D and fracture with genetic summary data and individual genotype data in UK biobank. The two-sample Mendelian randomization (MR) approach was used as an independent validation analysis. We applied the MiXeR method and conditional/conjunctional false discovery rate (ccFDR) approach to identify the shared genetic components between the traits. Finally, within the UK biobank dataset, the stratified cox regression analyses were applied to explore the association between T2D and fracture risk by including different number of the T2D-related risk factors. As complement, the relationship between T2D and BMD was also investigated.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The genetically predicted type 2 diabetes and fracture</title><p>The overall study design was presented in <xref ref-type="fig" rid="fig1">Figure 1</xref>. We first assessed the relationship between genetically predicted T2D and fracture in theUK biobank dataset with the wGRS analysis. Within the 294,571 UK biobank samples (<xref ref-type="fig" rid="fig1">Figure 1</xref>), we constructed the wGRS for the individuals in the UK Biobank with the 404 SNPs, which were independently associated with type 2 diabetes (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). The wGRS of the 404 SNPs were strongly associated with type 2 diabetes in UK Biobank data (OR = 1.6, p&lt;2.0 × 10<sup>–16</sup>), suggesting that the instruments were powerful for the MR analysis. When we regressed the observed fracture on the wGRS, we found that the genetically determined type 2 diabetes was associated with a lower risk of fracture (OR = 0.982, 95%CI = 0.975–0.989, p=0.006) (adjusting for reference age, sex, BMI, physical activity, fall history, HbA1c, and medication treatments) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). When we classified the fracture sites into weight-bearing bones (neck, vertebrae, pelvic, femur, tibia) and other bones, it indicated that there was a trend of protective association between T2D wGRS and weight-bearing bones fracture (OR = 0.9772, 95%CI = 0.9552–0.9997, p=0.04737, N of fracture = 8992, N of non-fracture=265,262), and other bones fracture (OR = 0.9838, 95%CI = 0.9688–0.9991, p=0.0386, N of fracture = 20,317, N of non-fracture=265,262) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We further estimated the effect of sex interaction on fracture risk with T2D <italic>wGRS × sex</italic> interaction term in the regression model, and no significant interactions were identified for fracture risk (p=0.5576). Moreover, we conducted the stratified analysis by sex and identified similar trends of association (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Meanwhile, the genetically determined type 2 diabetes was associated with higher BMD in pooled samples (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) and in both males and females (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Flow chart of the overall study design.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89281-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>The matching information of 14,860 patients with fractures.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89281-fig1-figsupp1-v1.tif"/></fig></fig-group><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>The association of genetically predicted type 2 diabetes with fracture and bone mineral density (BMD) by using different Mendelian randomization (MR methods).</title><p>(<bold>A</bold>) The genetically predicted type 2 diabetes and fracture. (<bold>B</bold>) The genetically predicted type 2 diabetes and BMD. (<bold>C</bold>) Visualized the association of lead SNPs for type 2 diabetes with the risk of fracture. Abbreviations: wGRS, weighted genetic risk score; MR-PRESSO, MR pleiotropy residual sum and outlier.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89281-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>The regression between type 2 diabetes GRS and fracture risk/bone mineral density (BMD) in male and female.</title><p>Models were adjusted for reference age, sex, BMI, physical activity, fall history, HbA1c, and medication treatments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89281-fig2-figsupp1-v1.tif"/></fig></fig-group><p>We also performed the two-sample MR analyses with fracture GWAS summary data (<xref ref-type="bibr" rid="bib52">Trajanoska et al., 2018</xref>) which is independent of UK Biobank samples. The inverse variance weighting (IVW) method showed a causal effect of genetically predicted T2D on low fracture risk (OR = 0.965, 95%CI = 0.943–0.988, p=0.003) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) using 298 SNPs as the instruments (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). This causal relationship was also significant in the simple median test (OR = 0.967, 95%CI = 0.936–0.997, p=0.033) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). There was heterogeneity in IVW results (Q' p&lt;0.05), when we excluded pleiotropic variants using restrictive MR pleiotropy residual sum and outlier test (MR-PRESSO) method, the causal association was still detected between T2D and fracture (OR = 0.967, 95%CI = 0.945–0.989, p=0.004) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Moreover, the MR-egger regression also suggested an inverse association between T2D and fracture (OR = 0.9666, 95%CI = 0.9497–0.9828, p=0.0002) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). The individual effect of the SNPs for T2D on fracture was corrected by the false discovery rate (&lt;0.05) (<xref ref-type="bibr" rid="bib9">Benjamini and Hochberg, 1995</xref>), two of 298 lead SNPs (including rs4580892 near <italic>RSPO3</italic>) of T2D remained as potential regions which would also have effect on fracture (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). We also performed multivariable MR analysis to test the effect of T2D on fracture risk-adjusted for confounding factors. We found that T2D had a direct effect on decreased fracture risk adjusted for BMI (OR = 0.974, 95%CI = 0.953–0.995, p=0.017), and BMI mediated 9.03% of the protective effect (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>). Similarly, with BMD GWAS summary data (<xref ref-type="bibr" rid="bib35">Morris et al., 2019</xref>), IVW (<italic>β</italic>=0.041, 95%CI = 0.027–0.054, p=8.14 × 10<sup>–9</sup>), simple median (<italic>β</italic>=0.028, 95%CI = 0.020–0.036, p=6.59 × 10<sup>–13</sup>), and MR-PRESSO (<italic>β</italic>=0.029, 95%CI = 0.022–0.036, p=1.14 × 10<sup>–14</sup>) all showed a causal association between type 2 diabetes and BMD (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>). The multivariable MR analysis suggested that T2D also showed a direct effect on increased BMD after adjusting for BMI (<italic>β</italic>=0.042, 95%CI = 0.026–0.057, p=1.92 × 10<sup>–7</sup>) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>).</p></sec><sec id="s2-2"><title>The distinct signal shared by type 2 diabetes and fracture</title><p>Leveraging the genetic summary datasets, we first evaluated the genetic correlation among the traits and diseases by using LDSC (<xref ref-type="bibr" rid="bib11">Bulik-Sullivan et al., 2015a</xref>). It is found that the genetic correlation between type 2 diabetes and fracture was not significant, but with inverse direction (r<sub>g</sub> = −0.0114) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1e</xref>). Instead, we used MiXeR (<xref ref-type="bibr" rid="bib20">Frei et al., 2019a</xref>; <xref ref-type="bibr" rid="bib21">Frei et al., 2019b</xref>) to evaluate the polygenic overlap irrespective of the genetic correlation between T2D and fracture. As represented in Venn diagrams of shared and unique polygenic components (<xref ref-type="fig" rid="fig3">Figure 3a</xref>), the MiXeR analysis suggested that type 2 diabetes and fracture exhibited polygenic overlap, sharing 428 causal variants, in other words, 18% of variants (428 of 2370) associated with type 2 diabetes might contribute to the risk of fracture (Dice coefficient = 25.25%), and genetic correlation was observed (r<sub>g</sub> = –0.086) (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1f</xref>). Only 39% of shared variants between type 2 diabetes and fracture showed a concordant direction of the association, and the correlation of effect sizes within the shared polygenic component was negative (rho_<italic>β</italic> = −0.336) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1f</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>The Venn diagrams, conditional quantile-quantile (QQ) plots, and genetic variants jointly associated with type 2 diabetes and fracture/bone mineral density (BMD) at conjunctional false discovery rate (conjFDR) &lt;0.05.</title><p>(<bold>A</bold>) The shared number of variants between type 2 diabetes and fracture. (<bold>B</bold>) The conditional QQ plot of fracture given the association with type 2 diabetes at the level of p≤0.1, p≤0.01, p≤0.001. (<bold>C</bold>) The shared genetic loci between type 2 diabetes and fracture. (<bold>D</bold>) The shared number of variants between type 2 diabetes and BMD. (<bold>E</bold>) The conditional QQ plot of BMD given the association with type 2 diabetes at the level of p≤0.1, p≤0.01, p≤0.001. (<bold>F</bold>) The shared genetic loci between type 2 diabetes and BMD.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89281-fig3-v1.tif"/></fig><p>We used the ccFDR approach (<xref ref-type="bibr" rid="bib5">Andreassen et al., 2013b</xref>) to identify specific shared loci between type 2 diabetes and fracture from the GWAS summary statistics. The stratified conditional QQ plot was utilized to visualize the enrichment of association with fracture across varying significance thresholds for type 2 diabetes. We observed leftward deflected from the expected null line in QQ plot, which suggested the existence of a polygenic overlap between type 2 diabetes and fracture (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). The conjunctional false discovery rate (conjFDR) analysis identified 10 genomic loci shared between type 2 diabetes and fracture (<xref ref-type="fig" rid="fig3">Figure 3C</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g</xref>), with the top SNP rs4580892 in the intron of gene <italic>RSPO3</italic> (conjFDR = 1.45E-05). The shared loci showed mixed directions of allelic associations, with 7 of 10 shared loci had an inverse direction of effect between type 2 diabetes and fracture (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g</xref>). We found that the locus approximately 250 kb upstream and downstream of the gene <italic>RSPO3</italic> (hg19, chr6: 127189749–127689749) possessed many significant SNPs associated with type 2 diabetes and fracture (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>), with the nearest gene <italic>RSPO3</italic>. The top SNP rs4580892 had an inverse direction of effect between type 2 diabetes and fracture, where rs4580892_T allele was associated with increased type 2 diabetes risk (OR = 1.041227, p=8.46 × 10<sup>–9</sup>) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>) and decreased fracture risk (OR = 0.944, p=3.68 × 10<sup>–10</sup>) (<xref ref-type="fig" rid="fig4">Figure 4B</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>The distinct signal (<italic>RSPO3</italic>) shared by type 2 diabetes and fracture.</title><p>(<bold>A</bold>) The regional plot of the association of type 2 diabetes and <italic>RSPO3</italic> gene expression (adipose subcutaneous) within hg19: chr6:127189749–127689749 (<italic>RSPO3</italic> gene region ±250 kb window). (<bold>B</bold>) The regional plot of the association of fracture and <italic>RSPO3</italic> gene expression (adipose subcutaneous) in the same region. (<bold>C</bold>) The association of genetically predicted <italic>RSPO3</italic> gene expression with type 2 diabetes and fracture risk. (<bold>D</bold>) The association of genetically predicted <italic>RSPO3</italic> gene expression with BMI, waist circumference, waist-hip ratio, and MRI-derived visceral adipose. (<bold>E</bold>) The association of genetically predicted circulating RSPO3 with type 2 diabetes and fracture risk.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89281-fig4-v1.tif"/></fig><p>Furthermore, after merging the eQTL summary data of <italic>RSPO3</italic> in adipose subcutaneous with the summary data of type 2 diabetes and fracture, rs72959041 and rs1936806 were the top cis-eQTL for type 2 diabetes and fracture in GTEx database, respectively. By applying the SMR method (<xref ref-type="bibr" rid="bib59">Zhu et al., 2016</xref>), we found that the higher expression of <italic>RSPO3</italic> (ENSG00000146374) in adipose subcutaneous would be associated with increased the risk of type 2 diabetes (OR = 1.102, 95%CI = 1.031–1.179, p=0.004), but decreased the risk of fracture (OR = 0.695, 95%CI = 0.566–0.854, p=0.0005) (<xref ref-type="fig" rid="fig4">Figure 4C</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref>). Interestingly, in adipose subcutaneous, higher expression of <italic>RSPO3</italic> was associated with higher waist circumference (<italic>β</italic>=0.090, 95%CI = 0.029–0.151, p=0.004) and higher waist-hip ratio (<italic>β</italic>=0.204, 95%CI = 0.095–0.313, p=0.0002) (<xref ref-type="fig" rid="fig4">Figure 4D</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref>). Meanwhile, higher expression of <italic>RSPO3</italic> was associated with higher MRI-derived visceral adipose (<italic>β</italic>=0.199, 95%CI = 0.103–0.294, p=4.36 × 10<sup>–5</sup>) (<xref ref-type="fig" rid="fig4">Figure 4D</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref>). The association between the expression of <italic>RSPO3</italic> and BMI was not significant, but the direction is the same as the waist circumference (<xref ref-type="fig" rid="fig4">Figure 4D</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref>). Moreover, to estimate the impact of RSPO3 protein level on type 2 diabetes and fracture risk, we used the top SNP at rs4580892, a cis-pQTL for circulating RSPO3 (p=2.34  ×  10<sup>−11</sup>) identified by Sun et al in an independent dataset (<xref ref-type="bibr" rid="bib49">Sun et al., 2018</xref>), to instrument the circulating protein level of RSPO3. The MR analyses indicated that increased circulating RSPO3 was strongly associated with increased risk of type 2 diabetes (OR = 1.24, 95%CI = 1.16–1.34, p=7.86  ×  10<sup>−9</sup>), but reduced fracture risk (OR = 0.73, 95%CI = 0.66–0.81, p=4.1  ×  10<sup>−10</sup>) (<xref ref-type="fig" rid="fig4">Figure 4E</xref>).</p><p>Not surprisingly, type 2 diabetes showed a significant positive genetic correlation with BMD (r<sub>g</sub> = 0.0923, p=2.50 × 10<sup>–6</sup>) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1e</xref>). The MiXeR analysis suggested that 29% of variants (691 of 2370) associated with type 2 diabetes might contribute to BMD (Dice coefficient = 33.67%) (<xref ref-type="fig" rid="fig3">Figure 3D</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1f</xref>). The leftward deflected from the expected null line in the QQ plot suggested the existence of a polygenic overlap between type 2 diabetes and BMD (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). and the conjFDR analysis identified 661 genomic loci shared between type 2 diabetes and BMD, and 449 of 661 loci (68%) had concordant associations between type 2 diabetes and BMD (<xref ref-type="fig" rid="fig3">Figure 3F</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1i</xref>).</p></sec><sec id="s2-3"><title>Observed relationship between type 2 diabetes and fracture</title><p>Within the 352,879 UK Biobank participants (<xref ref-type="fig" rid="fig1">Figure 1</xref>), 13,817 (3.92%) developed type 2 diabetes during 2006 and 2015, with the mean duration of type 2 diabetes 8.34 years (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1j</xref>). Compared to those without diabetes, the participants with type 2 diabetes were older (63.20 vs 60.55, p&lt;2.2 × 10<sup>−16</sup>), and more likely to be men and smokers, and had a higher BMI (32.07 vs 27.08, p&lt;2.2 × 10<sup>−16</sup>) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1j</xref>). We identified 16,147 (4.6%) participants with fractures within the 352,879 UK Biobank participants (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1j</xref>).</p><p>Although we found that genetically predicted type 2 diabetes might not be associated with risk of fracture, we observed a higher risk of fracture in the type 2 diabetes patients in the Cox proportional hazards regression after adjusting for the reference age, sex, BMI, physical activity, HbA1c, medication treatments, and fall history (Model 0) (HR = 1.527, 95% CI 1.385–1.685, p&lt;2 × 10<sup>−16</sup>) (<xref ref-type="fig" rid="fig5">Figure 5A</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1k</xref>). And the average causal mediation effect (ACME) by BMI was protective with 30.2% of the intermediary effect, respectively (BMI: indirect effect = −0.003, p&lt;2 × 10<sup>–16</sup>) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1l</xref>). Similar findings were observed for both males and females (HR = 1.587, 95% CI 1.379–1.828, p=1.26 × 10<sup>−10</sup> in male, HR = 1.530, 95% CI 1.334–1.756, p=1.27 × 10<sup>−9</sup> in female) (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). When we additionally controlled for BMD, we still observed an increased risk of fracture in type 2 diabetes (HR = 1.574, 95% CI 1.425–1.739, p&lt;2 × 10<sup>−16</sup>) (Model 1) (<xref ref-type="fig" rid="fig5">Figure 5A</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1k</xref>). We also classified the fracture into weight-bearing bone fractures (neck, vertebrae, pelvic, femur, tibia) and other bones fracture. Similar trends of association were observed in model 0 (weight-bearing bones: HR = 1.792, 95% CI 1.555–2,065, p=8.25 × 10<sup>−16</sup>; other bones: HR = 1.337, 95% CI 1.167–1.531, p=2.85 × 10<sup>−5</sup>) and model 1 (weight-bearing bones: HR = 1.850, 95% CI 1.602–2,136, p&lt;2 × 10<sup>−16</sup>; other bones: HR = 1.377, 95% CI 1.199–1.580, p=5.54 × 10<sup>−6</sup>) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The regression between type 2 diabetes and fracture/bone mineral density (BMD) in the observational study.</title><p>(<bold>A</bold>) The relationship between type 2 diabetes and fracture in different sites including all fractures, weight-bearing bones, and other bones. Model 0 adjusted for reference age, sex, BMI, physical activity, fall history, HbA1c, and medication treatments; Model 1 adjusted for a+ BMD. (<bold>B</bold>) The stratified analyses between type 2 diabetes, and fracture based on the five T2D-related risk factors for fracture adjusted for the age and sex. (<bold>C</bold>) The relationship between type 2 diabetes and BMD and the stratified analyses based on the five T2D-related risk factors for fracture adjusted for the age and sex. The five risk factors were: (1) BMI ≤25 kg/m<sup>2</sup>; (2) no physical activity; (3) falls in the last year; (4) HbA1c≥47.5 mmol/mol; (5) antidiabetic medication treatments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89281-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>The regression between type 2 diabetes and fracture risk/bone mineral density (BMD) in male and female in the observational study.</title><p>Model 0 adjusted for reference age, sex, BMI, physical activity, fall history, HbA1c, and medication treatments; Model 1 adjusted for a+ BMD.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89281-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>The stratified analyses between type 2 diabetes and fracture/bone mineral density (BMD) based on the five T2D-related risk factors for fracture (BMI ≤25 kg/m<sup>2</sup>, no physical activity, falls in the last year, HbA1c≥47.5 mmol/mol and antidiabetic medication treatments) in male and female.</title><p>Models were adjusted for the age and sex.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89281-fig5-figsupp2-v1.tif"/></fig></fig-group><p>Inspired by the MR analyses that genetically determined T2D might not be a risk factor for fracture, we conducted stratified analyses based on the T2D-related risk factors for fracture, such as BMI ≤25 kg/m<sup>2</sup>, no physical activity, falls in the last year, HbA1c≥47.5 mmol/mol and antidiabetic medication treatments. Within the 13,817 individuals with type 2 diabetes, 2303 patients carried none of the above risk factors, 4128 patients accompanied with one of the risk factors, and 4252 patients carried at least two risk factors (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1m</xref>). We performed stratified cox regression analysis and found that type 2 diabetes with at least two risk factors were associated with an increase in fracture risk (HR = 1.39, 95% CI 1.269–1.514, p=1.32 × 10<sup>−7</sup>) (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). It is interesting to note that including only one risk factor would attenuate the effect size of type 2 diabetes on fracture risk (HR = 1.20, 95%CI = 1.060–1.338, p=0.010). Furthermore, the association between type 2 diabetes and fracture was not significant (p=0.452) when analyzing the type 2 diabetes without risk factors (HR = 1.08, 95% CI 0.880–1.280, n=2303) (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Similar trends of association were observed in both males and females (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A</xref>). These results suggested that the T2D-related risk factors might contribute to the risk of fracture instead of the disease itself.</p><p>We also observed that participants with diabetes, despite they were older, had a significantly higher BMD than subjects without diabetes (0.57 vs 0.54, p&lt;2.2 × 10<sup>−16</sup>) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1j</xref>). In the multivariable linear regression analysis, the type 2 diabetes was found to be associated with increased BMD in the same model adjusted for age, sex, BMI, physical activity, fall history, HbA1c, and medication treatments (<italic>β</italic>=0.00957, p=1.35 × 10<sup>−10</sup>) (<xref ref-type="fig" rid="fig5">Figure 5C</xref><xref ref-type="supplementary-material" rid="supp1">Supplementary file 1k</xref>). We examined the relationship between type 2 diabetes and BMD in subgroups with varying numbers of risk factors. We observed that the effect size of type 2 diabetes on BMD decreased when the number of risk factors increased (no risk factors: in pooled <italic>β</italic>=0.023, p&lt;2 × 10<sup>−16</sup>, in male <italic>β</italic>=0.018, p=2.09 × 10<sup>−6</sup>, in female <italic>β</italic>=0.028, p=2.97 × 10<sup>−11</sup>; one risk factor: in pooled <italic>β</italic>=0.020, p&lt;2 × 10<sup>−16</sup>, in male <italic>β</italic>=0.015, p=1.91 × 10<sup>−7</sup>, in female <italic>β</italic>=0.0245, p=2.46 × 10<sup>−16</sup>; at least two risk factors: <italic>β</italic>=0.017, p&lt;2 × 10<sup>−16</sup>, in male <italic>β</italic>=0.0098, p=7.74 × 10<sup>−4</sup>, in female <italic>β</italic>=0.0250, p&lt;2 × 10<sup>−16</sup>) (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2B</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>By leveraging the genetic datasets, we found that the genetically predicted T2D was associated with higher BMD and lower risk of fracture in both one-sample MR (with 404 IVs) and two-sample MR (with 298 IVs). We also identified ten genomic loci shared between fracture and T2D, with the top signal at SNP rs4580892 in the intron of gene <italic>RSPO3</italic>. And the higher expression of <italic>RSPO3</italic> in adipose subcutaneous was associated with an increased risk of T2D, but a decreased risk of fracture. Similarly, the increased circulating RSPO3 was strongly associated with increased risk of T2D, but reduced fracture risk. In the prospective study, T2D was observed to be associated with a higher risk of fracture, but BMI mediated 30.2% of the protective effect. However, when stratified by the T2D-related risk factors for fracture, we observed that the effect size of T2D on the risk of fracture decreased when the number of T2D-related risk factors decreased, and the association became not significant if the T2D patients carried none of the risk factors.</p><p>The ‘diabetic bone paradox’ suggested that T2D patients would have higher areal BMD but higher fracture risk than individuals without T2D (<xref ref-type="bibr" rid="bib10">Botella Martínez et al., 2016</xref>; <xref ref-type="bibr" rid="bib41">Romero-Díaz et al., 2021</xref>). Other measurements, such as trabecular bone score (<xref ref-type="bibr" rid="bib19">Fazullina et al., 2022</xref>; <xref ref-type="bibr" rid="bib23">Ho-Pham and Nguyen, 2019</xref>) and chest CT texture analysis (<xref ref-type="bibr" rid="bib26">Kim et al., 2023</xref> ), could provide additional valuable information in the evaluation of fracture risk, especially in type 2 diabetes patients. As reviewed previously, heterogeneity could exist from study to study, and conflicting observational findings were reported (<xref ref-type="bibr" rid="bib25">Khosla et al., 2021</xref>). MR could be an alternative approach to infer the relationship between exposure and outcome, as this method exploits the idea that genotypes are distributed randomly at conception, facilitating their use as instrumental variables (IV) to alleviate the bias of the unknown confounding factors (<xref ref-type="bibr" rid="bib15">Davey Smith and Hemani, 2014</xref>; <xref ref-type="bibr" rid="bib57">Zhao et al., 2019</xref>). (<xref ref-type="bibr" rid="bib52">Trajanoska et al., 2018</xref>) assessed the effect of 15 selected clinical risk factors on the risk of fracture by using two-sample MR analysis, and reported a non-significant relationship between type 2 diabetes and fracture risk, but the direction of effect was negative (OR = 0.99). However, only 38 SNPs were extracted as instruments from a GWAS published in 2012 (<xref ref-type="bibr" rid="bib34">Morris et al., 2012</xref>). In the present study, we extracted 298 T2D-associated independent SNPs from <xref ref-type="bibr" rid="bib31">Mahajan et al., 2022</xref>, which is the largest-scale GWAS meta-analysis to date published in 2022, as the IVs in two-sample MR analysis. We reported that genetically determined type 2 diabetes was associated with a lower risk of fracture, even in multivariable MR analysis adjusted for BMI. In addition, we also calculated the wGRS with 404 T2D-associated independent SNPs in the UK Biobank dataset, and performed a regression analysis of wGRS of type 2 diabetes on the fracture risk (one-sample MR). Again, we found that the genetically predicted type 2 diabetes was associated with a lower risk of fracture in one-sample MR analysis. To be noted, two-sample MR results could be served as an independent replication to the one-sample MR results, because the effects of the outcome (fracture risk) for two-sample MR were derived from <xref ref-type="bibr" rid="bib52">Trajanoska et al., 2018</xref>, while the one-sample MR used the UK Biobank dataset, the study samples had no overlap. Furthermore, consistent with previous studies (<xref ref-type="bibr" rid="bib3">Ahmad et al., 2017</xref>; <xref ref-type="bibr" rid="bib33">Mitchell et al., 2021</xref>), the MR analysis in the present study suggested that the genetically predicted type 2 diabetes was associated with higher BMD. That is to say, by alleviating the bias of the unknown confounding factors through MR analysis, the genetically predicted type 2 diabetes did not show this bone paradox.</p><p>The genetic correlation between type 2 diabetes and fracture estimated by LDSC (<xref ref-type="bibr" rid="bib12">Bulik-Sullivan et al., 2015b</xref>) was not significant. It is hard for LDSC to identify the genetic pleiotropy with mixed-effect directions, which is what usually happens between two complex traits. Therefore, in this study, we employed the MiXeR method (<xref ref-type="bibr" rid="bib21">Frei et al., 2019b</xref>), which could identify the unique and shared polygenic SNPs between two traits regardless of genetic correlation. The MiXeR analysis suggested that type 2 diabetes and fracture exhibited polygenic overlap, and 61% of shared variants between type 2 diabetes and fracture showed a discordant direction of the association, and the correlation of effect sizes within the shared polygenic component was negative, suggesting an inverse genetic relationship between type 2 diabetes and fracture. Additionally, the conditional/conjunctional false discovery rate analysis (<xref ref-type="bibr" rid="bib5">Andreassen et al., 2013b</xref>) suggested a top locus at 6q22 (SNP rs4580892) jointly associated with type 2 diabetes and fracture. This SNP is an intronic variant in gene <italic>RSPO3</italic> (ENSG00000146374). We found that higher expression of <italic>RSPO3</italic> in adipose subcutaneous would be associated with increased risk of type 2 diabetes, but decreased risk of fracture. RSPO3 is a known WNT-signaling modulator (<xref ref-type="bibr" rid="bib8">Baron and Kneissel, 2013</xref> ; <xref ref-type="bibr" rid="bib28">Lerner and Ohlsson, 2015</xref>), which could bind to LRP5/6 to enhance the activity of osteoblast (<xref ref-type="bibr" rid="bib40">Richards et al., 2012</xref>). Karin et al., demonstrated that <italic>RSPO3</italic> is expressed in osteoprogenitor cells and osteoblasts, and that osteoblast-derived RSPO3 is the principal source of RSPO3 in bone and is an important regulator of vertebral trabecular bone mass and bone strength in adult mice (<xref ref-type="bibr" rid="bib37">Nilsson et al., 2021</xref>). Interestingly, we also found that higher expression of <italic>RSPO3</italic> was associated with higher waist circumference and higher waist-hip ratio. It was reported that RSPO3 could impact body fat distribution (<xref ref-type="bibr" rid="bib30">Loh et al., 2020</xref>), and fat distribution is an independent predictor of type 2 diabetes (<xref ref-type="bibr" rid="bib32">Manolopoulos et al., 2010</xref>). Therefore, we speculated that the different roles of the shared genetic components between bone metabolism and type 2 diabetes might provide one possible explanation for the inverse association pattern, and obese tendency might mediate this pattern. In fact, in UK Biobank, the participants with type 2 diabetes had a higher BMI compared to those without diabetes (31.74 vs 27.05, p&lt;2.2 × 10<sup>−16</sup>), and BMI mediated 30.2% of the intermediary effect between type 2 diabetes and fracture in our study.</p><p>On the contrary, in the observational study, we found that type 2 diabetes was associated with a higher risk of fracture even adjusted for a bunch of confounding factors such as the age, sex, BMI, physical activity, HbA1c, medication treatments, and fall history. When fractures were categorized into different sites (weight-bearing bones and other bones), the association between type 2 diabetes and fracture remained evident. Inspired by the MR analyses that genetically determined type 2 diabetes might not be a risk factor for fracture, we started to perform the stratified analyses based on the T2D-related risk factors. There are many secondary factors associated with type 2 diabetes that might contribute to fracture risk. Our previous study suggested that keeping a moderate-high BMI (overweight) might be of benefit to old people in terms of fracture risk (<xref ref-type="bibr" rid="bib62">Zhu et al., 2022</xref>), and an intensive lifestyle intervention, such as weight loss, in T2D patients might increase fracture risk (<xref ref-type="bibr" rid="bib24">Johnson et al., 2017</xref>). The hyperglycemia could cause osteocyte senescence and premature programmed cell death, leading to decreased ability to sense and respond to mechanical stimuli such as oscillatory shear stress, ultimately contributing to skeletal fragility (<xref ref-type="bibr" rid="bib18">Eckhardt et al., 2020</xref>). Another major and complicated factor that might influence the risk of fracture in T2D patients is the use of diabetes mellitus medications. For example, the use of insulin (<xref ref-type="bibr" rid="bib36">Napoli et al., 2014</xref>) or thiazolidinediones (<xref ref-type="bibr" rid="bib58">Zhu et al., 2014</xref>) was reported to be associated with an increased risk of fracture. In addition, the risk of falls, which might be triggered by some diabetic complications such as visual impairment and peripheral neuropathy, was suggested to increase in the patients with T2D (<xref ref-type="bibr" rid="bib45">Schwartz et al., 2002</xref>). Besides, low physical activity was identified as one of the most important independent diabetes-related risk factors for fracture through Gradient Boosting Machines (<xref ref-type="bibr" rid="bib6">Axelsson et al., 2023</xref>). Therefore, in this study, we stratified the T2D patients with five risk factors (BMI ≤25 kg/m<sup>2</sup>, no physical activity, falls in the last year, HbA1c≥47.5 mmol/mol, and antidiabetic medication treatment), and found that the observed effect size of type 2 diabetes on the risk of fracture decreased when the T2D-related risk factors decreased, and the association became not significant if the type 2 diabetes patients carried none of the risk factors. Unfortunately, we were unable to identify other significant confounding factors related to T2D for fracture. It was supposed that the observed effect of T2D on fracture risk should turn out to be protective when all significant confounding factors were stratified, just like the genetic analysis results. Anyway, the diabetic bone paradox might not exist if the T2D-related risk factors were eliminated. In a recent large-scale cohort study, four factors (duration of T2D, low physical activity, BMI, and insulin treatment) were identified as the important risk factors for fracture among the T2D patients, and the patients without the risk factors had lower fracture risk than their matched controls (<xref ref-type="bibr" rid="bib6">Axelsson et al., 2023</xref>). One previous study using the UK primary care data found no evidence to suggest a higher risk of fracture in type 2 diabetes patients (<xref ref-type="bibr" rid="bib16">Davie et al., 2021</xref>) and reported that significantly lower fracture risk was observed for overweight individuals (BMI 25–30 kg/m<sup>2</sup>) in type 2 diabetes than their counterparts without type 2 diabetes (<xref ref-type="bibr" rid="bib16">Davie et al., 2021</xref>).</p><p>In summary, by alleviating the bias of unknown confounding factors, we found that the genetically determined T2D did not show “bone paradox”. And the shared genetic architecture between T2D and fracture suggested a top signal near <italic>RSPO3</italic> gene. In addition, the stratified prospective regression analysis suggested that the effect size of T2D on the risk of fracture decreased if T2D-related risk factors could be eliminated. Therefore, it is important to manage the complications of T2D to prevent the risk of fracture.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Study participants and wGRS analysis</title><p>The UK Biobank data, the application 41376 as we used before (<xref ref-type="bibr" rid="bib7">Bai et al., 2020</xref>), was applied in this study under a prospective design. We identified the individuals with T2D and fracture using the ICD codes and self-report status. The detailed information on the field ID and codes for data extraction from UK Biobank was listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1n</xref>. We excluded participants if they were identified as follows: (1) ethnically identified as non-European (n=30,481); (2) diagnosed as type 1 diabetes (n=4455); (3) diagnosed with diseases associated with bone loss (n=21,560); (4) diagnosed as a fracture with known primary diseases (n=7222) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1o</xref>). For the remaining 439,982 samples, we further excluded 145,411 participants with relatedness (kinship) with others in the wGRS analysis (294,571 participants left) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). In addition, we classified the fracture into weight-bearing bones (neck, vertebrae, pelvic, femur, tibia) (N of fracture = 8992, N of non-fracture=285,579) and other bones (skull and facial, ribs, sternum, forearm, wrist and hand, foot, and other unspecified body regions) (N of fracture = 20,317, N of non-fracture=274,254) using the ICD codes and self-report status (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1p</xref>).</p><p>The summary-statistic data for the type 2 diabetes were obtained from a very recent GWAS consisting of 80,154 individuals with type 2 diabetes and 853,816 controls in the European population (with 10,454,875 SNPs)(<xref ref-type="bibr" rid="bib31">Mahajan et al., 2022</xref>). We drew a set of independent genetic variants with genome-wide significance (p&lt;5 × 10<sup>−8</sup>) from the type 2 diabetes summary-statistic data by LD clumping based on r<sup>2</sup> &lt;0.1 in 500 kb window to serve as instrumental variables (n=404) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). We constructed the wGRS for the individuals in the UK biobank (294,571 samples with genotypes) as a linear combination of the selected SNPs weighted by their β coefficients on type 2 diabetes: wGRS = β<sub>1</sub>×SNP<sub>1</sub> + β<sub>2</sub>×SNP<sub>2</sub> + … + βn×SNPn. n is the number of instrumental variables (here n=404 after LD clumping based on r<sup>2</sup> &lt;0.1 in 500 kb window). Next, cox proportional hazards regression and linear regression analyses were performed to analyze the association between the wGRS and fracture/BMD adjusted age, sex, BMI, physical activity, fall history, HbA1c, and medication treatments. Besides, regression modeling was used to estimate the effect of gene-environment interaction (T2D <italic>wGRS × sex</italic>) on fracture risk and BMD. In addition to the T2D <italic>wGRS × sex</italic> interaction term, the model was adjusted for covariates: age, sex, BMI, physical activity, fall history, HbA1c, and medication treatments.</p></sec><sec id="s4-2"><title>Two-sample MR analyses</title><p>To validate the wGRS results, we also performed the two-sample MR analyses that are independent of UK Biobank samples. The summary-statistic data for fracture (a discovery set of 37,857 fracture cases and 227,116 controls with 2,539,800 SNPs) (<xref ref-type="bibr" rid="bib52">Trajanoska et al., 2018</xref>) and BMD (426,824 samples and 13,753,401 SNPs) (<xref ref-type="bibr" rid="bib35">Morris et al., 2019</xref>) were extracted from the GEFOS consortium (<ext-link ext-link-type="uri" xlink:href="http://www.gefos.org/">http://www.gefos.org/</ext-link>), while the summary data for type 2 diabetes (<xref ref-type="bibr" rid="bib31">Mahajan et al., 2022</xref>) is the same as used in wGRS analysis.</p><p>We used the IVW (<xref ref-type="bibr" rid="bib13">Burgess et al., 2013</xref>), simple median and MR-PRESSO (<xref ref-type="bibr" rid="bib53">Verbanck et al., 2018</xref>) approaches in two-sample MR analyses. For the outcome of fracture, we merged the two summary datasets for T2D and fracture (<xref ref-type="bibr" rid="bib31">Mahajan et al., 2022</xref>; <xref ref-type="bibr" rid="bib52">Trajanoska et al., 2018</xref>) and got 2,479,475 overlapping SNPs, of which 6946 SNPs were genome-wide significant for type 2 diabetes. After LD clumping based on r<sup>2</sup> &lt;0.1 in 500 kb window, 298 independent genetic variants were left (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). Similarly, we got 9,204,694 overlapping SNPs for type 2 diabetes and BMD, and 389 independent genetic variants were left after LD clumping (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>). After harmonizing the effects so that they reflect the same allele, 289 (for fracture) and 380 (for BMD) SNPs were finally used in the IVW and simple median MR analysis. Because the presence of horizontal pleiotropy could bias the MR estimates, we additionally used the MR-PRESSO. The two-sample MR analyses were conducted in R version 4.0.2 using TwoSampleMR (<xref ref-type="bibr" rid="bib22">Hemani et al., 2018</xref>), MendelianRandomization (<xref ref-type="bibr" rid="bib56">Yavorska and Burgess, 2017</xref>) and MR-PRESSO (<xref ref-type="bibr" rid="bib53">Verbanck et al., 2018</xref>) packages. Moreover, we regressed the effects of these 298 SNPs of both traits to highlight the overall effect of T2D on fracture with ‘grs.summary’ function in the R package ‘gtx’ (<ext-link ext-link-type="uri" xlink:href="http://www2.uaem.mx/r-mirror/web/packages/gtx/gtx.pdf">http://www2.uaem.mx/r-mirror/web/packages/gtx/gtx.pdf</ext-link>).</p></sec><sec id="s4-3"><title>Multivariable Mendelian randomization (MVMR) analysis</title><p>Next, we conducted multivariable MR analysis (<xref ref-type="bibr" rid="bib42">Sanderson et al., 2019</xref>; <xref ref-type="bibr" rid="bib43">Sanderson et al., 2021a</xref>) to examine the direct effect of T2D on fracture and BMD adjusted for BMI with ‘MVMR’ R package (<xref ref-type="bibr" rid="bib44">Sanderson et al., 2021b</xref>). After adjusting for confounders, the effect of exposure on the outcome was considered to be a direct effect. Specifically, we first extracted the overlapping SNPs from the summary data for T2D (<xref ref-type="bibr" rid="bib31">Mahajan et al., 2022</xref>), BMI (<xref ref-type="bibr" rid="bib29">Locke et al., 2015</xref>), and fracture (<xref ref-type="bibr" rid="bib52">Trajanoska et al., 2018</xref>). Then the independent significant SNPs (p&lt;5 × 10<sup>−8</sup> and R<sup>2</sup> &lt;0.1) for either T2D or BMI were pooled as instruments. Additionally, we performed SNP harmonization to correct the orientation of alleles. The final IVs used in MVMR were presented in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1q</xref>.</p></sec><sec id="s4-4"><title>Infer the shared genetics</title><p>With the summary-statistic GWAS data of type 2 diabetes (<xref ref-type="bibr" rid="bib31">Mahajan et al., 2022</xref>), BMD (<xref ref-type="bibr" rid="bib35">Morris et al., 2019</xref>), and fracture (<xref ref-type="bibr" rid="bib52">Trajanoska et al., 2018</xref>), we performed genome-wide genetic correlation analysis between type 2 diabetes and fracture/BMD by using linkage disequilibrium score regression (LDSC) (<xref ref-type="bibr" rid="bib11">Bulik-Sullivan et al., 2015a</xref>; <xref ref-type="bibr" rid="bib12">Bulik-Sullivan et al., 2015b</xref>) which estimates the degree of shared genetic factors between two traits, We used MiXeR (<xref ref-type="bibr" rid="bib20">Frei et al., 2019a</xref>) to quantify polygenic overlap (e.g. how many unique and shared polygenic SNPs for type 2 diabetes and fracture) irrespective of genetic correlation (<xref ref-type="bibr" rid="bib21">Frei et al., 2019b</xref>). MiXeR models additive genetic effects as a mixture of four components, representing null SNPs in both traits (π<sub>0</sub>); SNPs with a specific effect on the first and on the second trait (π<sub>1</sub> and π<sub>2</sub>, respectively); and SNPs with non-zero effect on both traits (π<sub>12</sub>). The dice coefficient of two traits was estimated as <inline-formula><mml:math id="inf1"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mn>2</mml:mn><mml:mi>π</mml:mi></mml:mrow><mml:mrow><mml:mn>12</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mn>2</mml:mn><mml:mi>π</mml:mi></mml:mrow><mml:mrow><mml:mn>12</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math></inline-formula> (<xref ref-type="bibr" rid="bib21">Frei et al., 2019b</xref>). We constructed conditional quantile-quantile (QQ) plots which reveals the distribution of p values for fracture/BMD conditioning on the significance of association with type 2 diabetes at the level of p&lt;0.1, p&lt;0.01, and p&lt;0.001 to visualize polygenic enrichment (<xref ref-type="bibr" rid="bib47">Schwartzman and Lin, 2011</xref>). We used the ccFDR approach (<xref ref-type="bibr" rid="bib4">Andreassen et al., 2013a</xref>) to identify the specific shared loci (<xref ref-type="bibr" rid="bib5">Andreassen et al., 2013b</xref>). We used the conditional false discovery rate (condFDR) to detect SNPs associated with fracture-given associations with type 2 diabetes. We denoted condFDR for fracture-given associations with type 2 diabetes as condFDR(fracture|T2D) and <italic>vice versa</italic>, and considered the significance cutoff &lt;0.01. We used conjFDR to identify SNPs jointly associated with type 2 diabetes and fracture. After repeating the condFDR procedure for both traits, the conjFDR analysis reported the loci that exceed a condFDR significance threshold for two traits simultaneously (the maximum between the condFDRs for both traits), conjFDR &lt;0.05 was set as the significance.</p><p>We employed the Summary-data-based Mendelian randomization (SMR) method developed by colleagues (<xref ref-type="bibr" rid="bib59">Zhu et al., 2016</xref>) to test the association of the expression level of gene <italic>RSPO3</italic> with BMI (<xref ref-type="bibr" rid="bib29">Locke et al., 2015</xref>), waist circumference, waist-hip ratio (<xref ref-type="bibr" rid="bib48">Shungin et al., 2015</xref>) and MRI-derived visceral adipose (<xref ref-type="bibr" rid="bib2">Agrawal et al., 2022</xref>), type 2 diabetes and fracture using summary-level data from GWAS and expression quantitative trait loci (eQTL) data of the subcutaneous adipose tissue (9,962,255 SNPs included) from the GTEx database (release v8) (<ext-link ext-link-type="uri" xlink:href="https://www.gtexportal.org/home/">https://www.gtexportal.org/home/</ext-link>)(<xref ref-type="bibr" rid="bib14">Consortium and Laboratory, 2017</xref>). In the SMR analysis, the top cis-eQTL genetic variants were used as the instrumental variables (IVs) for gene expression. Additionally, we downloaded the cis-pQTL summary data for the circulating RSPO3 reported in the study by <xref ref-type="bibr" rid="bib49">Sun et al., 2018</xref>, and performed MR analyses to determine the association of circulating RSPO3 with type 2 diabetes and fracture risk using the IVW MR approach.</p></sec><sec id="s4-5"><title>Observational analyses</title><p>For the 439,982 UK biobank samples (see foregoing description of study participants), we only focused on the participants diagnosed with T2D within the 10 year period from 1 January 2006 to 31 December 2015, leaving 425,772 participants (with 14,860 type 2 diabetes patients) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Here, each type 2 diabetes patient had a diagnosis date, taking this date as the reference date, we first calculated the onset age, then among the participants who were free of T2D, we selected up to 27 participants (whenever possible) whose age at the reference date (±3 years) could be matching to the onset age as referents (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). In total, 363,884 non-T2D referents were individually matched with a 6 year age band at the reference date. We prospectively followed these type 2 diabetes patients and referents from the reference date until the diagnosis of fracture, death, emigration, 19 April 2021 (diagnose a fracture of the last person in the cohort), whichever came first. Survival time was calculated based on whether the patient had a fracture. If individuals had a fracture, the survival time is calculated as the time of the first diagnosis of fracture minus the reference date. If individuals did not have a fracture, it was defined as the minimum time of the reference date to diagnose a fracture of the last person in the cohort (19 April 2021), death, or emigration date. We excluded 25,865 participants with fracture diagnosis date, or death or emigration date before the reference date, leaving 352,879 participants included in the final analysis (13,817 type 2 diabetes patients and 339,062 referents) (<xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Cox proportional hazards regression, as a statistical method to analyze the effect of risk factors on the time it takes for a specific event to happen, was used to test the relationship between T2D and fracture. Meanwhile, multiple linear regression analyses were performed to test the association between T2D and BMD. Here, the BMD was estimated from quantitative ultrasound measurement at the heel. The use of the device generates two variables, including speed of sound (SOS) and BUA (the slope between the attenuation of the sound signal and its frequency as it travels through the bone and soft tissue). Heel BMD was calculated by the following formula: BMD = 0.002592 × (BUA +SOS)−3.687.</p><p>First, we adjusted for clinical risk factors including reference age, sex, BMI, physical activity, fall history, HbA1c, and medication treatments to examine the relationship between T2D and fracture/BMD (Model 0). To examine the intermediary effect of risk factors on the relationship between T2D and fracture, the mediation analysis was performed using the R packages of ‘mediation.’ Individuals treated with any glucose-lowering medication including insulin product, metformin, troglitazone, pioglitazone, rosiglitazone, tolbutamide, glibenclamide, gliclazide, glipizide, gliquidone, glimepiride, chlorpropamide, tolbutamide, repaglinide and nateglinide were recorded as having received medical treatment. We also included BMD as an additional confounding factor for fracture analysis as a complement to the basic model (Model 1). In addition, we classified the fracture into weight-bearing bones (neck, vertebrae, pelvic, femur, tibia) (N of fracture = 8992, N of non-fracture=285,579) and other bones (skull and facial, ribs, sternum, forearm, wrist and hand, foot and other unspecified body regions) (N of fracture = 20,317, N of non-fracture=274,254) using the ICD codes and self-report status (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1p</xref>). As we did in wGRS analysis, we classified the fracture into weight-bearing bones and other bones fracture. Briefly, 6582 (1.92%) participants were identified as weight-bearing bones and 9586 (2.77%) participants were identified as other bones. Second, we carried out stratified analyses between type 2 diabetes, fracture, and BMD based on the T2D-related risk factors for fracture. We took five clinical factors to classify the individuals at risk, for example, if an individual had BMI ≤25 kg/m<sup>2</sup>, no physical activity, falls in the last year, HbA1c≥47.5 mmol/mol, and antidiabetic medication treatment, this individual was identified to have five risk factors, and so forth. Based on the number of risk factors, we grouped 13,817 individuals with T2D into subgroup for analysis. This analysis was adjusted for reference age and sex. For the BMD analysis, the age when attended the assessment center was included in the analysis instead of the reference age.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Writing – original draft, clinical interpretation of the results</p></fn><fn fn-type="con" id="con3"><p>Writing – original draft, clinical interpretation of the results</p></fn><fn fn-type="con" id="con4"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All individuals provided written informed consent. The North West Multi-Centre Research Ethics Committee approved the UK Biobank ethical application (reference number: 16/NW/0274).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-89281-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Supplementary tables.</title><p>(<bold>a</bold>) Characteristics of the 404 single nucleotide polymorphisms associated with type 2 diabetes. (<bold>b</bold>) The information of 298 lead SNPs for type 2 diabetes with the risk of fracture. (<bold>c</bold>) Multivariable MR analysis of the direct effect of BMI on fracture risk and BMD. (<bold>d</bold>) The information of 389 SNPs for type 2 diabetes with BMD. (<bold>e</bold>) Summary of pariwise genetic correlation using linkage disequilibrium score regeression(LDSC). Abbreviations: p1 = trait 1, p2 = trait 2, rg = genetic correlation, se = standard error of rg, p = p-value for rg, gcov_int, gcov_int_se = cross-trait LD Score regression intercept and standard error. (<bold>f</bold>) The results of cross-trait analysis with MiXeR model for type 2 diabetes, fracture and BMD. Abbreviations: nc1@p9, nc2@p9, and nc12@p9 = the number of causal variants for trait1, trait2 and both, respectively; nc@p9 = number of trait-influencing variants specific to type 2 diabetes; rho_beta = the correlation of effect sizes within the shared polygenic component; rg = genetic correlation; concordant_fraction = the proportion of shared variants with concordant direction of effect in both traits on all shared variants; pi1@p9, pi2@p9, and pi12@p9 = polygenicity of trait1, trait2 and both, respectively; The best_vs_min_AIC and the best_vs_max_AIC indicates whether MiXeR can accurately distinguish the reported overlap from the minimum and maximum possible overlap allowed, respectively. (<bold>g</bold>) Distinct genomic loci shared between type 2 diabetes and fracture at conjFDR&lt;0.05. (<bold>h</bold>) The results of SMR analysis for the expression of RSPO3 (ENSG00000146374) with type 2 diabetes, fracture, BMI, WC, WHR and VAT in adipose subcutaneous. (<bold>i</bold>) Distinct genomic loci shared between type 2 diabetes and BMD at conjFDR&lt;0.05. (<bold>j</bold>) The characteristics of participants and comparison between individuals with and without type 2 diabetes. (<bold>k</bold>) The regression between type 2 diabetes, fracture and BMD. (<bold>l</bold>) Assessment of the mediators (BMI) for the association between type 2 diabetes and fracture. (<bold>m</bold>) Baseline characteristics of participants with different Numbers of Risk Factors. (<bold>n</bold>) Detailed information on the field ID and codes for participants included in UK Biobank. Abbreviations: ICD-9, the International Classification of Diseases, 9th Revision; ICD-10, the International Classification of Diseases, 10th Revision. (<bold>o</bold>) The International Classification of Diseases (ICD) codes and self-reported codes for excluded diseases. (<bold>p</bold>) Detailed information on the field ID and codes for specific fracture sites included in UK Biobank. (<bold>q</bold>) Detailed information for instrumental variables of T2D and BMI on fracture and BMD.</p></caption><media xlink:href="elife-89281-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated during this study are included in the manuscript. Summary-level analysis was conducted using publicly available data as described below. Data for fracture was extracted from <xref ref-type="bibr" rid="bib52">Trajanoska et al., 2018</xref>, and downloaded from the <ext-link ext-link-type="uri" xlink:href="http://www.gefos.org/?q=content/fracture-gwas-2018-release">GEnetic Factors for OSteoporosis (GEFOS) website</ext-link>. Data for BMD GWAS was extracted from <xref ref-type="bibr" rid="bib35">Morris et al., 2019</xref>, and downloaded from the same <ext-link ext-link-type="uri" xlink:href="http://www.gefos.org/q=content/fracture-gwas-2018-release">GEFOS website</ext-link>. T2D data was obtained from the <ext-link ext-link-type="uri" xlink:href="http://diagram-consortium.org/downloads.html">DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium</ext-link> under &quot;Ancestry specific GWAS meta-analysis summary statistics: European&quot; published in <xref ref-type="bibr" rid="bib31">Mahajan et al., 2022</xref>. Data for BMI, WC and WHR GWAS was downloaded from the Genetic Investigation of ANthropometric Traits (GIANT) Consortium at <ext-link ext-link-type="uri" xlink:href="https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files">https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files</ext-link>, under &quot;GWAS Anthropometric 2015 BMI Summary Statistics (subtitle: Download BMI EUR Ancestry GZIP)&quot; published in <xref ref-type="bibr" rid="bib29">Locke et al., 2015</xref>, and under &quot;GWAS Anthropometric 2015 Waist Summary Statistics (subtitle: WC: Download WC Combined EUR GZIP and WHR: Download WHR Combined EUR GZIP)&quot; published in <xref ref-type="bibr" rid="bib48">Shungin et al., 2015</xref>. Data for MRI-derived visceral adipose could be downloaded from the <ext-link ext-link-type="uri" xlink:href="https://cvd.hugeamp.org/downloads.html#summary">Cardiovascular Disease Knowledge Portal (CADKP)</ext-link>, under &quot;Fat distribution 2022 GWAS&quot; published in <xref ref-type="bibr" rid="bib2">Agrawal et al., 2022</xref>. Data for eQTL data could be obtained from Genotype-Tissue Expression Portal (<ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/home/downloads/adult-gtex/qtl">GTEx_Analysis_v8_eQTL</ext-link>). Additionally, summary association results for the cis-pQTL were downloaded from <xref ref-type="bibr" rid="bib49">Sun et al., 2018</xref>, which is available at <ext-link ext-link-type="uri" xlink:href="https://wbbc.westlake.edu.cn/downloads_proteins.html">https://wbbc.westlake.edu.cn/downloads_proteins.html</ext-link> (RSPO3.13094.75.3). Please note that individual-level genetic and phenotype data require permission from the <ext-link ext-link-type="uri" xlink:href="https://www.ukbiobank.ac.uk">UK Biobank</ext-link> with accession ID 41376.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thankfully acknowledge the High-performance Computing Center at Westlake.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adami</surname><given-names>G</given-names></name><name><surname>Gatti</surname><given-names>D</given-names></name><name><surname>Rossini</surname><given-names>M</given-names></name><name><surname>Orsolini</surname><given-names>G</given-names></name><name><surname>Pollastri</surname><given-names>F</given-names></name><name><surname>Bertoldo</surname><given-names>E</given-names></name><name><surname>Viapiana</surname><given-names>O</given-names></name><name><surname>Bertoldo</surname><given-names>F</given-names></name><name><surname>Giollo</surname><given-names>A</given-names></name><name><surname>Fassio</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort</article-title><source>Osteoporosis International</source><volume>31</volume><fpage>2113</fpage><lpage>2122</lpage><pub-id pub-id-type="doi">10.1007/s00198-020-05519-5</pub-id><pub-id pub-id-type="pmid">32613408</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Klarqvist</surname><given-names>MDR</given-names></name><name><surname>Smith</surname><given-names>K</given-names></name><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Dashti</surname><given-names>H</given-names></name><name><surname>Diamant</surname><given-names>N</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Jurgens</surname><given-names>SJ</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><name><surname>Philippakis</surname><given-names>A</given-names></name><name><surname>Claussnitzer</surname><given-names>M</given-names></name><name><surname>Ng</surname><given-names>K</given-names></name><name><surname>Udler</surname><given-names>MS</given-names></name><name><surname>Batra</surname><given-names>P</given-names></name><name><surname>Khera</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Inherited basis of visceral, abdominal subcutaneous and gluteofemoral fat depots</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>3771</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-30931-2</pub-id><pub-id pub-id-type="pmid">35773277</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>OS</given-names></name><name><surname>Leong</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>JA</given-names></name><name><surname>Morris</surname><given-names>JA</given-names></name><name><surname>Forgetta</surname><given-names>V</given-names></name><name><surname>Mujammami</surname><given-names>M</given-names></name><name><surname>Richards</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A mendelian randomization study of the effect of type-2 diabetes and glycemic traits on bone mineral density</article-title><source>Journal of Bone and Mineral Research</source><volume>32</volume><fpage>1072</fpage><lpage>1081</lpage><pub-id pub-id-type="doi">10.1002/jbmr.3063</pub-id><pub-id pub-id-type="pmid">27982478</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Andreassen</surname><given-names>OA</given-names></name><name><surname>Thompson</surname><given-names>WK</given-names></name><name><surname>Schork</surname><given-names>AJ</given-names></name><name><surname>Ripke</surname><given-names>S</given-names></name><name><surname>Mattingsdal</surname><given-names>M</given-names></name><name><surname>Kelsoe</surname><given-names>JR</given-names></name><name><surname>Kendler</surname><given-names>KS</given-names></name><name><surname>O’Donovan</surname><given-names>MC</given-names></name><name><surname>Rujescu</surname><given-names>D</given-names></name><name><surname>Werge</surname><given-names>T</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>Roddey</surname><given-names>JC</given-names></name><name><surname>Chen</surname><given-names>CH</given-names></name><name><surname>McEvoy</surname><given-names>L</given-names></name><name><surname>Desikan</surname><given-names>RS</given-names></name><name><surname>Djurovic</surname><given-names>S</given-names></name><name><surname>Dale</surname><given-names>AM</given-names></name><collab>Psychiatric Genomics Consortium (PGC)</collab><collab>Bipolar Disorder and Schizophrenia Working Groups</collab></person-group><year iso-8601-date="2013">2013a</year><data-title>Pleiofdr</data-title><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/precimed/pleiofdr">https://github.com/precimed/pleiofdr</ext-link></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreassen</surname><given-names>OA</given-names></name><name><surname>Thompson</surname><given-names>WK</given-names></name><name><surname>Schork</surname><given-names>AJ</given-names></name><name><surname>Ripke</surname><given-names>S</given-names></name><name><surname>Mattingsdal</surname><given-names>M</given-names></name><name><surname>Kelsoe</surname><given-names>JR</given-names></name><name><surname>Kendler</surname><given-names>KS</given-names></name><name><surname>O’Donovan</surname><given-names>MC</given-names></name><name><surname>Rujescu</surname><given-names>D</given-names></name><name><surname>Werge</surname><given-names>T</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><collab>Psychiatric Genomics Consortium (PGC)</collab><collab>Bipolar Disorder and Schizophrenia Working Groups</collab><name><surname>Roddey</surname><given-names>JC</given-names></name><name><surname>Chen</surname><given-names>CH</given-names></name><name><surname>McEvoy</surname><given-names>L</given-names></name><name><surname>Desikan</surname><given-names>RS</given-names></name><name><surname>Djurovic</surname><given-names>S</given-names></name><name><surname>Dale</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003455</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003455</pub-id><pub-id pub-id-type="pmid">23637625</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axelsson</surname><given-names>KF</given-names></name><name><surname>Litsne</surname><given-names>H</given-names></name><name><surname>Kousoula</surname><given-names>K</given-names></name><name><surname>Franzén</surname><given-names>S</given-names></name><name><surname>Eliasson</surname><given-names>B</given-names></name><name><surname>Lorentzon</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Risk of fracture in adults with type 2 diabetes in Sweden: q national cohort study</article-title><source>PLOS Medicine</source><volume>20</volume><elocation-id>e1004172</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1004172</pub-id><pub-id pub-id-type="pmid">36701363</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>WY</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Ying</surname><given-names>ZM</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>GQ</given-names></name><name><surname>Cong</surname><given-names>PK</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Zou</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>HF</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Identification of PIEZO1 polymorphisms for human bone mineral density</article-title><source>Bone</source><volume>133</volume><elocation-id>115247</elocation-id><pub-id pub-id-type="doi">10.1016/j.bone.2020.115247</pub-id><pub-id pub-id-type="pmid">31968281</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron</surname><given-names>R</given-names></name><name><surname>Kneissel</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>WNT signaling in bone homeostasis and disease: from human mutations to treatments</article-title><source>Nature Medicine</source><volume>19</volume><fpage>179</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1038/nm.3074</pub-id><pub-id pub-id-type="pmid">23389618</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname><given-names>Y</given-names></name><name><surname>Hochberg</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title><source>Journal of the Royal Statistical Society</source><volume>57</volume><fpage>289</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1111/j.2517-6161.1995.tb02031.x</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botella Martínez</surname><given-names>S</given-names></name><name><surname>Varo Cenarruzabeitia</surname><given-names>N</given-names></name><name><surname>Escalada San Martin</surname><given-names>J</given-names></name><name><surname>Calleja Canelas</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The diabetic paradox: bone mineral density and fracture in type 2 diabetes</article-title><source>Endocrinologia y Nutricion</source><volume>63</volume><fpage>495</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1016/j.endonu.2016.06.004</pub-id><pub-id pub-id-type="pmid">27481443</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulik-Sullivan</surname><given-names>B</given-names></name><name><surname>Finucane</surname><given-names>HK</given-names></name><name><surname>Anttila</surname><given-names>V</given-names></name><name><surname>Gusev</surname><given-names>A</given-names></name><name><surname>Day</surname><given-names>FR</given-names></name><name><surname>Loh</surname><given-names>PR</given-names></name><name><surname>Duncan</surname><given-names>L</given-names></name><name><surname>Perry</surname><given-names>JRB</given-names></name><name><surname>Patterson</surname><given-names>N</given-names></name><name><surname>Robinson</surname><given-names>EB</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Price</surname><given-names>AL</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>An atlas of genetic correlations across human diseases and traits</article-title><source>Nature Genetics</source><volume>47</volume><fpage>1236</fpage><lpage>1241</lpage><pub-id pub-id-type="doi">10.1038/ng.3406</pub-id><pub-id pub-id-type="pmid">26414676</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulik-Sullivan</surname><given-names>BK</given-names></name><name><surname>Loh</surname><given-names>PR</given-names></name><name><surname>Finucane</surname><given-names>HK</given-names></name><name><surname>Ripke</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Patterson</surname><given-names>N</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Price</surname><given-names>AL</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>LD score regression distinguishes confounding from polygenicity in genome-wide association studies</article-title><source>Nature Genetics</source><volume>47</volume><fpage>291</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1038/ng.3211</pub-id><pub-id pub-id-type="pmid">25642630</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgess</surname><given-names>S</given-names></name><name><surname>Butterworth</surname><given-names>A</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mendelian randomization analysis with multiple genetic variants using summarized data</article-title><source>Genetic Epidemiology</source><volume>37</volume><fpage>658</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1002/gepi.21758</pub-id><pub-id pub-id-type="pmid">24114802</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Consortium</surname><given-names>GT</given-names></name><name><surname>Laboratory</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Coordinating center -analysis working: genetic effects on gene expression across human tissues</article-title><source>Nature</source><volume>550</volume><fpage>204</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1038/nature24277</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Hemani</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mendelian randomization: genetic anchors for causal inference in epidemiological studies</article-title><source>Human Molecular Genetics</source><volume>23</volume><fpage>R89</fpage><lpage>R98</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddu328</pub-id><pub-id pub-id-type="pmid">25064373</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davie</surname><given-names>GS</given-names></name><name><surname>Pal</surname><given-names>K</given-names></name><name><surname>Orton</surname><given-names>E</given-names></name><name><surname>Tyrrell</surname><given-names>EG</given-names></name><name><surname>Petersen</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Incident type 2 diabetes and risk of fracture: A comparative cohort analysis using u.K. Primary care records</article-title><source>Diabetes Care</source><volume>44</volume><fpage>58</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.2337/dc20-1220</pub-id><pub-id pub-id-type="pmid">33148635</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diamond</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The double puzzle of diabetes</article-title><source>Nature</source><volume>423</volume><fpage>599</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1038/423599a</pub-id><pub-id pub-id-type="pmid">12789325</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckhardt</surname><given-names>BA</given-names></name><name><surname>Rowsey</surname><given-names>JL</given-names></name><name><surname>Thicke</surname><given-names>BS</given-names></name><name><surname>Fraser</surname><given-names>DG</given-names></name><name><surname>O’Grady</surname><given-names>KL</given-names></name><name><surname>Bondar</surname><given-names>OP</given-names></name><name><surname>Hines</surname><given-names>JM</given-names></name><name><surname>Singh</surname><given-names>RJ</given-names></name><name><surname>Thoreson</surname><given-names>AR</given-names></name><name><surname>Rakshit</surname><given-names>K</given-names></name><name><surname>Lagnado</surname><given-names>AB</given-names></name><name><surname>Passos</surname><given-names>JF</given-names></name><name><surname>Vella</surname><given-names>A</given-names></name><name><surname>Matveyenko</surname><given-names>AV</given-names></name><name><surname>Khosla</surname><given-names>S</given-names></name><name><surname>Monroe</surname><given-names>DG</given-names></name><name><surname>Farr</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Accelerated osteocyte senescence and skeletal fragility in mice with type 2 diabetes</article-title><source>JCI Insight</source><volume>5</volume><elocation-id>e135236</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.135236</pub-id><pub-id pub-id-type="pmid">32267250</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fazullina</surname><given-names>ON</given-names></name><name><surname>Korbut</surname><given-names>AI</given-names></name><name><surname>Klimontov</surname><given-names>VV</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Factors associated with trabecular bone score in postmenopausal women with type 2 diabetes and normal bone mineral density</article-title><source>World Journal of Diabetes</source><volume>13</volume><fpage>553</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.4239/wjd.v13.i7.553</pub-id><pub-id pub-id-type="pmid">36051426</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Frei</surname><given-names>O</given-names></name><name><surname>Holland</surname><given-names>D</given-names></name><name><surname>Smeland</surname><given-names>OB</given-names></name><name><surname>Shadrin</surname><given-names>AA</given-names></name><name><surname>Fan</surname><given-names>CC</given-names></name><name><surname>Maeland</surname><given-names>S</given-names></name><name><surname>O’Connell</surname><given-names>KS</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Djurovic</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>WK</given-names></name><name><surname>Andreassen</surname><given-names>OA</given-names></name><name><surname>Dale</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2019">2019a</year><data-title>MiXeR</data-title><version designator="1.2.0">1.2.0</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/precimed/mixer">https://github.com/precimed/mixer</ext-link></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frei</surname><given-names>O</given-names></name><name><surname>Holland</surname><given-names>D</given-names></name><name><surname>Smeland</surname><given-names>OB</given-names></name><name><surname>Shadrin</surname><given-names>AA</given-names></name><name><surname>Fan</surname><given-names>CC</given-names></name><name><surname>Maeland</surname><given-names>S</given-names></name><name><surname>O’Connell</surname><given-names>KS</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Djurovic</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>WK</given-names></name><name><surname>Andreassen</surname><given-names>OA</given-names></name><name><surname>Dale</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>Bivariate causal mixture model quantifies polygenic overlap between complex traits beyond genetic correlation</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>2417</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-10310-0</pub-id><pub-id pub-id-type="pmid">31160569</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemani</surname><given-names>G</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Elsworth</surname><given-names>B</given-names></name><name><surname>Wade</surname><given-names>KH</given-names></name><name><surname>Haberland</surname><given-names>V</given-names></name><name><surname>Baird</surname><given-names>D</given-names></name><name><surname>Laurin</surname><given-names>C</given-names></name><name><surname>Burgess</surname><given-names>S</given-names></name><name><surname>Bowden</surname><given-names>J</given-names></name><name><surname>Langdon</surname><given-names>R</given-names></name><name><surname>Tan</surname><given-names>VY</given-names></name><name><surname>Yarmolinsky</surname><given-names>J</given-names></name><name><surname>Shihab</surname><given-names>HA</given-names></name><name><surname>Timpson</surname><given-names>NJ</given-names></name><name><surname>Evans</surname><given-names>DM</given-names></name><name><surname>Relton</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>RM</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Gaunt</surname><given-names>TR</given-names></name><name><surname>Haycock</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The MR-Base platform supports systematic causal inference across the human phenome</article-title><source>eLife</source><volume>7</volume><elocation-id>e34408</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.34408</pub-id><pub-id pub-id-type="pmid">29846171</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho-Pham</surname><given-names>LT</given-names></name><name><surname>Nguyen</surname><given-names>TV</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Association between trabecular bone score and type 2 diabetes: a quantitative update of evidence</article-title><source>Osteoporosis International</source><volume>30</volume><fpage>2079</fpage><lpage>2085</lpage><pub-id pub-id-type="doi">10.1007/s00198-019-05053-z</pub-id><pub-id pub-id-type="pmid">31214749</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>KC</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Cheskin</surname><given-names>LJ</given-names></name><name><surname>Clark</surname><given-names>JM</given-names></name><name><surname>Egan</surname><given-names>CM</given-names></name><name><surname>Foreyt</surname><given-names>JP</given-names></name><name><surname>Garcia</surname><given-names>KR</given-names></name><name><surname>Glasser</surname><given-names>S</given-names></name><name><surname>Greenway</surname><given-names>FL</given-names></name><name><surname>Gregg</surname><given-names>EW</given-names></name><name><surname>Hazuda</surname><given-names>HP</given-names></name><name><surname>Hergenroeder</surname><given-names>A</given-names></name><name><surname>Hill</surname><given-names>JO</given-names></name><name><surname>Horton</surname><given-names>ES</given-names></name><name><surname>Jakicic</surname><given-names>JM</given-names></name><name><surname>Jeffery</surname><given-names>RW</given-names></name><name><surname>Kahn</surname><given-names>SE</given-names></name><name><surname>Knowler</surname><given-names>WC</given-names></name><name><surname>Lewis</surname><given-names>CE</given-names></name><name><surname>Miller</surname><given-names>M</given-names></name><name><surname>Montez</surname><given-names>MG</given-names></name><name><surname>Nathan</surname><given-names>DM</given-names></name><name><surname>Patricio</surname><given-names>JL</given-names></name><name><surname>Peters</surname><given-names>AL</given-names></name><name><surname>Pi-Sunyer</surname><given-names>X</given-names></name><name><surname>Pownall</surname><given-names>HJ</given-names></name><name><surname>Reboussin</surname><given-names>D</given-names></name><name><surname>Redmon</surname><given-names>JB</given-names></name><name><surname>Steinberg</surname><given-names>H</given-names></name><name><surname>Wadden</surname><given-names>TA</given-names></name><name><surname>Wagenknecht</surname><given-names>LE</given-names></name><name><surname>Wing</surname><given-names>RR</given-names></name><name><surname>Womack</surname><given-names>CR</given-names></name><name><surname>Yanovski</surname><given-names>SZ</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Schwartz</surname><given-names>AV</given-names></name><collab>Look AHEAD Study Group</collab></person-group><year iso-8601-date="2017">2017</year><article-title>The effect of intentional weight loss on fracture risk in persons with diabetes: Results from the look ahead randomized clinical trial</article-title><source>Journal of Bone and Mineral Research</source><volume>32</volume><fpage>2278</fpage><lpage>2287</lpage><pub-id pub-id-type="doi">10.1002/jbmr.3214</pub-id><pub-id pub-id-type="pmid">28678345</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khosla</surname><given-names>S</given-names></name><name><surname>Samakkarnthai</surname><given-names>P</given-names></name><name><surname>Monroe</surname><given-names>DG</given-names></name><name><surname>Farr</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus</article-title><source>Nature Reviews. Endocrinology</source><volume>17</volume><fpage>685</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1038/s41574-021-00555-5</pub-id><pub-id pub-id-type="pmid">34518671</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MW</given-names></name><name><surname>Huh</surname><given-names>JW</given-names></name><name><surname>Noh</surname><given-names>YM</given-names></name><name><surname>Seo</surname><given-names>HE</given-names></name><name><surname>Lee</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Exploring the paradox of bone mineral density in type 2 diabetes: A comparative study using opportunistic chest ct texture analysis and dxa</article-title><source>Diagnostics</source><volume>13</volume><elocation-id>2784</elocation-id><pub-id pub-id-type="doi">10.3390/diagnostics13172784</pub-id><pub-id pub-id-type="pmid">37685322</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>WS</given-names></name><name><surname>Kindler</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Insulin resistance and skeletal health</article-title><source>Current Opinion in Endocrinology, Diabetes, and Obesity</source><volume>29</volume><fpage>343</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1097/MED.0000000000000738</pub-id><pub-id pub-id-type="pmid">35749301</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerner</surname><given-names>UH</given-names></name><name><surname>Ohlsson</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The WNT system: background and its role in bone</article-title><source>Journal of Internal Medicine</source><volume>277</volume><fpage>630</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1111/joim.12368</pub-id><pub-id pub-id-type="pmid">25845559</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locke</surname><given-names>AE</given-names></name><name><surname>Kahali</surname><given-names>B</given-names></name><name><surname>Berndt</surname><given-names>SI</given-names></name><name><surname>Justice</surname><given-names>AE</given-names></name><name><surname>Pers</surname><given-names>TH</given-names></name><name><surname>Day</surname><given-names>FR</given-names></name><name><surname>Powell</surname><given-names>C</given-names></name><name><surname>Vedantam</surname><given-names>S</given-names></name><name><surname>Buchkovich</surname><given-names>ML</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Croteau-Chonka</surname><given-names>DC</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Fall</surname><given-names>T</given-names></name><name><surname>Ferreira</surname><given-names>T</given-names></name><name><surname>Gustafsson</surname><given-names>S</given-names></name><name><surname>Kutalik</surname><given-names>Z</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Mägi</surname><given-names>R</given-names></name><name><surname>Randall</surname><given-names>JC</given-names></name><name><surname>Winkler</surname><given-names>TW</given-names></name><name><surname>Wood</surname><given-names>AR</given-names></name><name><surname>Workalemahu</surname><given-names>T</given-names></name><name><surname>Faul</surname><given-names>JD</given-names></name><name><surname>Smith</surname><given-names>JA</given-names></name><name><surname>Zhao</surname><given-names>JH</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Fehrmann</surname><given-names>R</given-names></name><name><surname>Hedman</surname><given-names>ÅK</given-names></name><name><surname>Karjalainen</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>EM</given-names></name><name><surname>Absher</surname><given-names>D</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Anderson</surname><given-names>D</given-names></name><name><surname>Beekman</surname><given-names>M</given-names></name><name><surname>Bolton</surname><given-names>JL</given-names></name><name><surname>Bragg-Gresham</surname><given-names>JL</given-names></name><name><surname>Buyske</surname><given-names>S</given-names></name><name><surname>Demirkan</surname><given-names>A</given-names></name><name><surname>Deng</surname><given-names>G</given-names></name><name><surname>Ehret</surname><given-names>GB</given-names></name><name><surname>Feenstra</surname><given-names>B</given-names></name><name><surname>Feitosa</surname><given-names>MF</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Kanoni</surname><given-names>S</given-names></name><name><surname>Kleber</surname><given-names>ME</given-names></name><name><surname>Kristiansson</surname><given-names>K</given-names></name><name><surname>Lim</surname><given-names>U</given-names></name><name><surname>Lotay</surname><given-names>V</given-names></name><name><surname>Mangino</surname><given-names>M</given-names></name><name><surname>Leach</surname><given-names>IM</given-names></name><name><surname>Medina-Gomez</surname><given-names>C</given-names></name><name><surname>Medland</surname><given-names>SE</given-names></name><name><surname>Nalls</surname><given-names>MA</given-names></name><name><surname>Palmer</surname><given-names>CD</given-names></name><name><surname>Pasko</surname><given-names>D</given-names></name><name><surname>Pechlivanis</surname><given-names>S</given-names></name><name><surname>Peters</surname><given-names>MJ</given-names></name><name><surname>Prokopenko</surname><given-names>I</given-names></name><name><surname>Shungin</surname><given-names>D</given-names></name><name><surname>Stančáková</surname><given-names>A</given-names></name><name><surname>Strawbridge</surname><given-names>RJ</given-names></name><name><surname>Sung</surname><given-names>YJ</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Trompet</surname><given-names>S</given-names></name><name><surname>van der Laan</surname><given-names>SW</given-names></name><name><surname>van Setten</surname><given-names>J</given-names></name><name><surname>Van Vliet-Ostaptchouk</surname><given-names>JV</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yengo</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Isaacs</surname><given-names>A</given-names></name><name><surname>Albrecht</surname><given-names>E</given-names></name><name><surname>Ärnlöv</surname><given-names>J</given-names></name><name><surname>Arscott</surname><given-names>GM</given-names></name><name><surname>Attwood</surname><given-names>AP</given-names></name><name><surname>Bandinelli</surname><given-names>S</given-names></name><name><surname>Barrett</surname><given-names>A</given-names></name><name><surname>Bas</surname><given-names>IN</given-names></name><name><surname>Bellis</surname><given-names>C</given-names></name><name><surname>Bennett</surname><given-names>AJ</given-names></name><name><surname>Berne</surname><given-names>C</given-names></name><name><surname>Blagieva</surname><given-names>R</given-names></name><name><surname>Blüher</surname><given-names>M</given-names></name><name><surname>Böhringer</surname><given-names>S</given-names></name><name><surname>Bonnycastle</surname><given-names>LL</given-names></name><name><surname>Böttcher</surname><given-names>Y</given-names></name><name><surname>Boyd</surname><given-names>HA</given-names></name><name><surname>Bruinenberg</surname><given-names>M</given-names></name><name><surname>Caspersen</surname><given-names>IH</given-names></name><name><surname>Chen</surname><given-names>YDI</given-names></name><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Daw</surname><given-names>EW</given-names></name><name><surname>de Craen</surname><given-names>AJM</given-names></name><name><surname>Delgado</surname><given-names>G</given-names></name><name><surname>Dimitriou</surname><given-names>M</given-names></name><name><surname>Doney</surname><given-names>ASF</given-names></name><name><surname>Eklund</surname><given-names>N</given-names></name><name><surname>Estrada</surname><given-names>K</given-names></name><name><surname>Eury</surname><given-names>E</given-names></name><name><surname>Folkersen</surname><given-names>L</given-names></name><name><surname>Fraser</surname><given-names>RM</given-names></name><name><surname>Garcia</surname><given-names>ME</given-names></name><name><surname>Geller</surname><given-names>F</given-names></name><name><surname>Giedraitis</surname><given-names>V</given-names></name><name><surname>Gigante</surname><given-names>B</given-names></name><name><surname>Go</surname><given-names>AS</given-names></name><name><surname>Golay</surname><given-names>A</given-names></name><name><surname>Goodall</surname><given-names>AH</given-names></name><name><surname>Gordon</surname><given-names>SD</given-names></name><name><surname>Gorski</surname><given-names>M</given-names></name><name><surname>Grabe</surname><given-names>HJ</given-names></name><name><surname>Grallert</surname><given-names>H</given-names></name><name><surname>Grammer</surname><given-names>TB</given-names></name><name><surname>Gräßler</surname><given-names>J</given-names></name><name><surname>Grönberg</surname><given-names>H</given-names></name><name><surname>Groves</surname><given-names>CJ</given-names></name><name><surname>Gusto</surname><given-names>G</given-names></name><name><surname>Haessler</surname><given-names>J</given-names></name><name><surname>Hall</surname><given-names>P</given-names></name><name><surname>Haller</surname><given-names>T</given-names></name><name><surname>Hallmans</surname><given-names>G</given-names></name><name><surname>Hartman</surname><given-names>CA</given-names></name><name><surname>Hassinen</surname><given-names>M</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Heard-Costa</surname><given-names>NL</given-names></name><name><surname>Helmer</surname><given-names>Q</given-names></name><name><surname>Hengstenberg</surname><given-names>C</given-names></name><name><surname>Holmen</surname><given-names>O</given-names></name><name><surname>Hottenga</surname><given-names>JJ</given-names></name><name><surname>James</surname><given-names>AL</given-names></name><name><surname>Jeff</surname><given-names>JM</given-names></name><name><surname>Johansson</surname><given-names>Å</given-names></name><name><surname>Jolley</surname><given-names>J</given-names></name><name><surname>Juliusdottir</surname><given-names>T</given-names></name><name><surname>Kinnunen</surname><given-names>L</given-names></name><name><surname>Koenig</surname><given-names>W</given-names></name><name><surname>Koskenvuo</surname><given-names>M</given-names></name><name><surname>Kratzer</surname><given-names>W</given-names></name><name><surname>Laitinen</surname><given-names>J</given-names></name><name><surname>Lamina</surname><given-names>C</given-names></name><name><surname>Leander</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>NR</given-names></name><name><surname>Lichtner</surname><given-names>P</given-names></name><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Lindström</surname><given-names>J</given-names></name><name><surname>Lo</surname><given-names>KS</given-names></name><name><surname>Lobbens</surname><given-names>S</given-names></name><name><surname>Lorbeer</surname><given-names>R</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Mach</surname><given-names>F</given-names></name><name><surname>Magnusson</surname><given-names>PKE</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>McArdle</surname><given-names>WL</given-names></name><name><surname>McLachlan</surname><given-names>S</given-names></name><name><surname>Menni</surname><given-names>C</given-names></name><name><surname>Merger</surname><given-names>S</given-names></name><name><surname>Mihailov</surname><given-names>E</given-names></name><name><surname>Milani</surname><given-names>L</given-names></name><name><surname>Moayyeri</surname><given-names>A</given-names></name><name><surname>Monda</surname><given-names>KL</given-names></name><name><surname>Morken</surname><given-names>MA</given-names></name><name><surname>Mulas</surname><given-names>A</given-names></name><name><surname>Müller</surname><given-names>G</given-names></name><name><surname>Müller-Nurasyid</surname><given-names>M</given-names></name><name><surname>Musk</surname><given-names>AW</given-names></name><name><surname>Nagaraja</surname><given-names>R</given-names></name><name><surname>Nöthen</surname><given-names>MM</given-names></name><name><surname>Nolte</surname><given-names>IM</given-names></name><name><surname>Pilz</surname><given-names>S</given-names></name><name><surname>Rayner</surname><given-names>NW</given-names></name><name><surname>Renstrom</surname><given-names>F</given-names></name><name><surname>Rettig</surname><given-names>R</given-names></name><name><surname>Ried</surname><given-names>JS</given-names></name><name><surname>Ripke</surname><given-names>S</given-names></name><name><surname>Robertson</surname><given-names>NR</given-names></name><name><surname>Rose</surname><given-names>LM</given-names></name><name><surname>Sanna</surname><given-names>S</given-names></name><name><surname>Scharnagl</surname><given-names>H</given-names></name><name><surname>Scholtens</surname><given-names>S</given-names></name><name><surname>Schumacher</surname><given-names>FR</given-names></name><name><surname>Scott</surname><given-names>WR</given-names></name><name><surname>Seufferlein</surname><given-names>T</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Smolonska</surname><given-names>J</given-names></name><name><surname>Stanton</surname><given-names>AV</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Stirrups</surname><given-names>K</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Sundström</surname><given-names>J</given-names></name><name><surname>Swertz</surname><given-names>MA</given-names></name><name><surname>Swift</surname><given-names>AJ</given-names></name><name><surname>Syvänen</surname><given-names>AC</given-names></name><name><surname>Tan</surname><given-names>ST</given-names></name><name><surname>Tayo</surname><given-names>BO</given-names></name><name><surname>Thorand</surname><given-names>B</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Tyrer</surname><given-names>JP</given-names></name><name><surname>Uh</surname><given-names>HW</given-names></name><name><surname>Vandenput</surname><given-names>L</given-names></name><name><surname>Verhulst</surname><given-names>FC</given-names></name><name><surname>Vermeulen</surname><given-names>SH</given-names></name><name><surname>Verweij</surname><given-names>N</given-names></name><name><surname>Vonk</surname><given-names>JM</given-names></name><name><surname>Waite</surname><given-names>LL</given-names></name><name><surname>Warren</surname><given-names>HR</given-names></name><name><surname>Waterworth</surname><given-names>D</given-names></name><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>Wilkens</surname><given-names>LR</given-names></name><name><surname>Willenborg</surname><given-names>C</given-names></name><name><surname>Wilsgaard</surname><given-names>T</given-names></name><name><surname>Wojczynski</surname><given-names>MK</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Wright</surname><given-names>AF</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><collab>LifeLines Cohort Study</collab><name><surname>Brennan</surname><given-names>EP</given-names></name><name><surname>Choi</surname><given-names>M</given-names></name><name><surname>Dastani</surname><given-names>Z</given-names></name><name><surname>Drong</surname><given-names>AW</given-names></name><name><surname>Eriksson</surname><given-names>P</given-names></name><name><surname>Franco-Cereceda</surname><given-names>A</given-names></name><name><surname>Gådin</surname><given-names>JR</given-names></name><name><surname>Gharavi</surname><given-names>AG</given-names></name><name><surname>Goddard</surname><given-names>ME</given-names></name><name><surname>Handsaker</surname><given-names>RE</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Keildson</surname><given-names>S</given-names></name><name><surname>Kiryluk</surname><given-names>K</given-names></name><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Lifton</surname><given-names>RP</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>McKnight</surname><given-names>AJ</given-names></name><name><surname>Min</surname><given-names>JL</given-names></name><name><surname>Moffatt</surname><given-names>MF</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Murabito</surname><given-names>JM</given-names></name><name><surname>Nicholson</surname><given-names>G</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Perry</surname><given-names>JRB</given-names></name><name><surname>Dorajoo</surname><given-names>R</given-names></name><name><surname>Reinmaa</surname><given-names>E</given-names></name><name><surname>Salem</surname><given-names>RM</given-names></name><name><surname>Sandholm</surname><given-names>N</given-names></name><name><surname>Scott</surname><given-names>RA</given-names></name><name><surname>Stolk</surname><given-names>L</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>van ’t Hooft</surname><given-names>FM</given-names></name><name><surname>Vinkhuyzen</surname><given-names>AAE</given-names></name><name><surname>Westra</surname><given-names>HJ</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>Zondervan</surname><given-names>KT</given-names></name><collab>ADIPOGen Consortium</collab><collab>AGEN-BMI Working Group</collab><collab>CARDIOGRAMplusC4D Consortium</collab><collab>CKDGen Consortium</collab><collab>GLGC</collab><collab>ICBP</collab><collab>MAGIC Investigators</collab><collab>MuTHER Consortium</collab><collab>MIGen Consortium</collab><collab>PAGE Consortium</collab><collab>ReproGen Consortium</collab><collab>GENIE Consortium</collab><collab>International Endogene Consortium</collab><name><surname>Heath</surname><given-names>AC</given-names></name><name><surname>Arveiler</surname><given-names>D</given-names></name><name><surname>Bakker</surname><given-names>SJL</given-names></name><name><surname>Beilby</surname><given-names>J</given-names></name><name><surname>Bergman</surname><given-names>RN</given-names></name><name><surname>Blangero</surname><given-names>J</given-names></name><name><surname>Bovet</surname><given-names>P</given-names></name><name><surname>Campbell</surname><given-names>H</given-names></name><name><surname>Caulfield</surname><given-names>MJ</given-names></name><name><surname>Cesana</surname><given-names>G</given-names></name><name><surname>Chakravarti</surname><given-names>A</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Chines</surname><given-names>PS</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Crawford</surname><given-names>DC</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Cusi</surname><given-names>D</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>de Faire</surname><given-names>U</given-names></name><name><surname>den Ruijter</surname><given-names>HM</given-names></name><name><surname>Dominiczak</surname><given-names>AF</given-names></name><name><surname>Erbel</surname><given-names>R</given-names></name><name><surname>Erdmann</surname><given-names>J</given-names></name><name><surname>Eriksson</surname><given-names>JG</given-names></name><name><surname>Farrall</surname><given-names>M</given-names></name><name><surname>Felix</surname><given-names>SB</given-names></name><name><surname>Ferrannini</surname><given-names>E</given-names></name><name><surname>Ferrières</surname><given-names>J</given-names></name><name><surname>Ford</surname><given-names>I</given-names></name><name><surname>Forouhi</surname><given-names>NG</given-names></name><name><surname>Forrester</surname><given-names>T</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><name><surname>Gansevoort</surname><given-names>RT</given-names></name><name><surname>Gejman</surname><given-names>PV</given-names></name><name><surname>Gieger</surname><given-names>C</given-names></name><name><surname>Gottesman</surname><given-names>O</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Gyllensten</surname><given-names>U</given-names></name><name><surname>Hall</surname><given-names>AS</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>Hicks</surname><given-names>AA</given-names></name><name><surname>Hindorff</surname><given-names>LA</given-names></name><name><surname>Hingorani</surname><given-names>AD</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Homuth</surname><given-names>G</given-names></name><name><surname>Hovingh</surname><given-names>GK</given-names></name><name><surname>Humphries</surname><given-names>SE</given-names></name><name><surname>Hunt</surname><given-names>SC</given-names></name><name><surname>Hyppönen</surname><given-names>E</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>Jacobs</surname><given-names>KB</given-names></name><name><surname>Jarvelin</surname><given-names>MR</given-names></name><name><surname>Jöckel</surname><given-names>KH</given-names></name><name><surname>Johansen</surname><given-names>B</given-names></name><name><surname>Jousilahti</surname><given-names>P</given-names></name><name><surname>Jukema</surname><given-names>JW</given-names></name><name><surname>Jula</surname><given-names>AM</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Kastelein</surname><given-names>JJP</given-names></name><name><surname>Keinanen-Kiukaanniemi</surname><given-names>SM</given-names></name><name><surname>Kiemeney</surname><given-names>LA</given-names></name><name><surname>Knekt</surname><given-names>P</given-names></name><name><surname>Kooner</surname><given-names>JS</given-names></name><name><surname>Kooperberg</surname><given-names>C</given-names></name><name><surname>Kovacs</surname><given-names>P</given-names></name><name><surname>Kraja</surname><given-names>AT</given-names></name><name><surname>Kumari</surname><given-names>M</given-names></name><name><surname>Kuusisto</surname><given-names>J</given-names></name><name><surname>Lakka</surname><given-names>TA</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Marchand</surname><given-names>LL</given-names></name><name><surname>Lehtimäki</surname><given-names>T</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Männistö</surname><given-names>S</given-names></name><name><surname>Marette</surname><given-names>A</given-names></name><name><surname>Matise</surname><given-names>TC</given-names></name><name><surname>McKenzie</surname><given-names>CA</given-names></name><name><surname>McKnight</surname><given-names>B</given-names></name><name><surname>Moll</surname><given-names>FL</given-names></name><name><surname>Morris</surname><given-names>AD</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Murray</surname><given-names>JC</given-names></name><name><surname>Nelis</surname><given-names>M</given-names></name><name><surname>Ohlsson</surname><given-names>C</given-names></name><name><surname>Oldehinkel</surname><given-names>AJ</given-names></name><name><surname>Ong</surname><given-names>KK</given-names></name><name><surname>Madden</surname><given-names>PAF</given-names></name><name><surname>Pasterkamp</surname><given-names>G</given-names></name><name><surname>Peden</surname><given-names>JF</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Postma</surname><given-names>DS</given-names></name><name><surname>Pramstaller</surname><given-names>PP</given-names></name><name><surname>Price</surname><given-names>JF</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Rankinen</surname><given-names>T</given-names></name><name><surname>Rao</surname><given-names>DC</given-names></name><name><surname>Rice</surname><given-names>TK</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Rioux</surname><given-names>JD</given-names></name><name><surname>Ritchie</surname><given-names>MD</given-names></name><name><surname>Rudan</surname><given-names>I</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Samani</surname><given-names>NJ</given-names></name><name><surname>Saramies</surname><given-names>J</given-names></name><name><surname>Sarzynski</surname><given-names>MA</given-names></name><name><surname>Schunkert</surname><given-names>H</given-names></name><name><surname>Schwarz</surname><given-names>PEH</given-names></name><name><surname>Sever</surname><given-names>P</given-names></name><name><surname>Shuldiner</surname><given-names>AR</given-names></name><name><surname>Sinisalo</surname><given-names>J</given-names></name><name><surname>Stolk</surname><given-names>RP</given-names></name><name><surname>Strauch</surname><given-names>K</given-names></name><name><surname>Tönjes</surname><given-names>A</given-names></name><name><surname>Trégouët</surname><given-names>DA</given-names></name><name><surname>Tremblay</surname><given-names>A</given-names></name><name><surname>Tremoli</surname><given-names>E</given-names></name><name><surname>Virtamo</surname><given-names>J</given-names></name><name><surname>Vohl</surname><given-names>MC</given-names></name><name><surname>Völker</surname><given-names>U</given-names></name><name><surname>Waeber</surname><given-names>G</given-names></name><name><surname>Willemsen</surname><given-names>G</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Zillikens</surname><given-names>MC</given-names></name><name><surname>Adair</surname><given-names>LS</given-names></name><name><surname>Amouyel</surname><given-names>P</given-names></name><name><surname>Asselbergs</surname><given-names>FW</given-names></name><name><surname>Assimes</surname><given-names>TL</given-names></name><name><surname>Bochud</surname><given-names>M</given-names></name><name><surname>Boehm</surname><given-names>BO</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Bornstein</surname><given-names>SR</given-names></name><name><surname>Bottinger</surname><given-names>EP</given-names></name><name><surname>Bouchard</surname><given-names>C</given-names></name><name><surname>Cauchi</surname><given-names>S</given-names></name><name><surname>Chambers</surname><given-names>JC</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name><name><surname>Cooper</surname><given-names>RS</given-names></name><name><surname>de Bakker</surname><given-names>PIW</given-names></name><name><surname>Dedoussis</surname><given-names>G</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Franks</surname><given-names>PW</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Groop</surname><given-names>LC</given-names></name><name><surname>Haiman</surname><given-names>CA</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><name><surname>Hui</surname><given-names>J</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Hveem</surname><given-names>K</given-names></name><name><surname>Kaplan</surname><given-names>RC</given-names></name><name><surname>Kivimaki</surname><given-names>M</given-names></name><name><surname>Kuh</surname><given-names>D</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>März</surname><given-names>W</given-names></name><name><surname>Melbye</surname><given-names>M</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Moebus</surname><given-names>S</given-names></name><name><surname>Munroe</surname><given-names>PB</given-names></name><name><surname>Njølstad</surname><given-names>I</given-names></name><name><surname>Oostra</surname><given-names>BA</given-names></name><name><surname>Palmer</surname><given-names>CNA</given-names></name><name><surname>Pedersen</surname><given-names>NL</given-names></name><name><surname>Perola</surname><given-names>M</given-names></name><name><surname>Pérusse</surname><given-names>L</given-names></name><name><surname>Peters</surname><given-names>U</given-names></name><name><surname>Power</surname><given-names>C</given-names></name><name><surname>Quertermous</surname><given-names>T</given-names></name><name><surname>Rauramaa</surname><given-names>R</given-names></name><name><surname>Rivadeneira</surname><given-names>F</given-names></name><name><surname>Saaristo</surname><given-names>TE</given-names></name><name><surname>Saleheen</surname><given-names>D</given-names></name><name><surname>Sattar</surname><given-names>N</given-names></name><name><surname>Schadt</surname><given-names>EE</given-names></name><name><surname>Schlessinger</surname><given-names>D</given-names></name><name><surname>Slagboom</surname><given-names>PE</given-names></name><name><surname>Snieder</surname><given-names>H</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Stumvoll</surname><given-names>M</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Uusitupa</surname><given-names>M</given-names></name><name><surname>van der Harst</surname><given-names>P</given-names></name><name><surname>Walker</surname><given-names>M</given-names></name><name><surname>Wallaschofski</surname><given-names>H</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Watkins</surname><given-names>H</given-names></name><name><surname>Weir</surname><given-names>DR</given-names></name><name><surname>Wichmann</surname><given-names>HE</given-names></name><name><surname>Wilson</surname><given-names>JF</given-names></name><name><surname>Zanen</surname><given-names>P</given-names></name><name><surname>Borecki</surname><given-names>IB</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Heid</surname><given-names>IM</given-names></name><name><surname>O’Connell</surname><given-names>JR</given-names></name><name><surname>Strachan</surname><given-names>DP</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Franke</surname><given-names>L</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Scherag</surname><given-names>A</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Beckmann</surname><given-names>JS</given-names></name><name><surname>Barroso</surname><given-names>I</given-names></name><name><surname>North</surname><given-names>KE</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Speliotes</surname><given-names>EK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genetic studies of body mass index yield new insights for obesity biology</article-title><source>Nature</source><volume>518</volume><fpage>197</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1038/nature14177</pub-id><pub-id pub-id-type="pmid">25673413</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loh</surname><given-names>NY</given-names></name><name><surname>Minchin</surname><given-names>JEN</given-names></name><name><surname>Pinnick</surname><given-names>KE</given-names></name><name><surname>Verma</surname><given-names>M</given-names></name><name><surname>Todorčević</surname><given-names>M</given-names></name><name><surname>Denton</surname><given-names>N</given-names></name><name><surname>Moustafa</surname><given-names>JES</given-names></name><name><surname>Kemp</surname><given-names>JP</given-names></name><name><surname>Gregson</surname><given-names>CL</given-names></name><name><surname>Evans</surname><given-names>DM</given-names></name><name><surname>Neville</surname><given-names>MJ</given-names></name><name><surname>Small</surname><given-names>KS</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Rawls</surname><given-names>JF</given-names></name><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Christodoulides</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>RSPO3 impacts body fat distribution and regulates adipose cell biology in vitro</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>2797</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-16592-z</pub-id><pub-id pub-id-type="pmid">32493999</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Spracklen</surname><given-names>CN</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Ng</surname><given-names>MCY</given-names></name><name><surname>Petty</surname><given-names>LE</given-names></name><name><surname>Kitajima</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>GZ</given-names></name><name><surname>Rüeger</surname><given-names>S</given-names></name><name><surname>Speidel</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Horikoshi</surname><given-names>M</given-names></name><name><surname>Mercader</surname><given-names>JM</given-names></name><name><surname>Taliun</surname><given-names>D</given-names></name><name><surname>Moon</surname><given-names>S</given-names></name><name><surname>Kwak</surname><given-names>SH</given-names></name><name><surname>Robertson</surname><given-names>NR</given-names></name><name><surname>Rayner</surname><given-names>NW</given-names></name><name><surname>Loh</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>BJ</given-names></name><name><surname>Chiou</surname><given-names>J</given-names></name><name><surname>Miguel-Escalada</surname><given-names>I</given-names></name><name><surname>Della Briotta Parolo</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>K</given-names></name><name><surname>Bragg</surname><given-names>F</given-names></name><name><surname>Preuss</surname><given-names>MH</given-names></name><name><surname>Takeuchi</surname><given-names>F</given-names></name><name><surname>Nano</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Lamri</surname><given-names>A</given-names></name><name><surname>Nakatochi</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>RA</given-names></name><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Huerta-Chagoya</surname><given-names>A</given-names></name><name><surname>Graff</surname><given-names>M</given-names></name><name><surname>Chai</surname><given-names>JF</given-names></name><name><surname>Parra</surname><given-names>EJ</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Bielak</surname><given-names>LF</given-names></name><name><surname>Tabara</surname><given-names>Y</given-names></name><name><surname>Hai</surname><given-names>Y</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Cook</surname><given-names>JP</given-names></name><name><surname>Kals</surname><given-names>M</given-names></name><name><surname>Grarup</surname><given-names>N</given-names></name><name><surname>Schmidt</surname><given-names>EM</given-names></name><name><surname>Pan</surname><given-names>I</given-names></name><name><surname>Sofer</surname><given-names>T</given-names></name><name><surname>Wuttke</surname><given-names>M</given-names></name><name><surname>Sarnowski</surname><given-names>C</given-names></name><name><surname>Gieger</surname><given-names>C</given-names></name><name><surname>Nousome</surname><given-names>D</given-names></name><name><surname>Trompet</surname><given-names>S</given-names></name><name><surname>Long</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Tong</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>WM</given-names></name><name><surname>Ahmad</surname><given-names>M</given-names></name><name><surname>Noordam</surname><given-names>R</given-names></name><name><surname>Lim</surname><given-names>VJY</given-names></name><name><surname>Tam</surname><given-names>CHT</given-names></name><name><surname>Joo</surname><given-names>YY</given-names></name><name><surname>Chen</surname><given-names>CH</given-names></name><name><surname>Raffield</surname><given-names>LM</given-names></name><name><surname>Lecoeur</surname><given-names>C</given-names></name><name><surname>Prins</surname><given-names>BP</given-names></name><name><surname>Nicolas</surname><given-names>A</given-names></name><name><surname>Yanek</surname><given-names>LR</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Jensen</surname><given-names>RA</given-names></name><name><surname>Tajuddin</surname><given-names>S</given-names></name><name><surname>Kabagambe</surname><given-names>EK</given-names></name><name><surname>An</surname><given-names>P</given-names></name><name><surname>Xiang</surname><given-names>AH</given-names></name><name><surname>Choi</surname><given-names>HS</given-names></name><name><surname>Cade</surname><given-names>BE</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Flanagan</surname><given-names>J</given-names></name><name><surname>Abaitua</surname><given-names>F</given-names></name><name><surname>Adair</surname><given-names>LS</given-names></name><name><surname>Adeyemo</surname><given-names>A</given-names></name><name><surname>Aguilar-Salinas</surname><given-names>CA</given-names></name><name><surname>Akiyama</surname><given-names>M</given-names></name><name><surname>Anand</surname><given-names>SS</given-names></name><name><surname>Bertoni</surname><given-names>A</given-names></name><name><surname>Bian</surname><given-names>Z</given-names></name><name><surname>Bork-Jensen</surname><given-names>J</given-names></name><name><surname>Brandslund</surname><given-names>I</given-names></name><name><surname>Brody</surname><given-names>JA</given-names></name><name><surname>Brummett</surname><given-names>CM</given-names></name><name><surname>Buchanan</surname><given-names>TA</given-names></name><name><surname>Canouil</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>JCN</given-names></name><name><surname>Chang</surname><given-names>LC</given-names></name><name><surname>Chee</surname><given-names>ML</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>SH</given-names></name><name><surname>Chen</surname><given-names>YT</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Chuang</surname><given-names>LM</given-names></name><name><surname>Cushman</surname><given-names>M</given-names></name><name><surname>Das</surname><given-names>SK</given-names></name><name><surname>de Silva</surname><given-names>HJ</given-names></name><name><surname>Dedoussis</surname><given-names>G</given-names></name><name><surname>Dimitrov</surname><given-names>L</given-names></name><name><surname>Doumatey</surname><given-names>AP</given-names></name><name><surname>Du</surname><given-names>S</given-names></name><name><surname>Duan</surname><given-names>Q</given-names></name><name><surname>Eckardt</surname><given-names>KU</given-names></name><name><surname>Emery</surname><given-names>LS</given-names></name><name><surname>Evans</surname><given-names>DS</given-names></name><name><surname>Evans</surname><given-names>MK</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Floyd</surname><given-names>JS</given-names></name><name><surname>Ford</surname><given-names>I</given-names></name><name><surname>Fornage</surname><given-names>M</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Freedman</surname><given-names>BI</given-names></name><name><surname>Fuchsberger</surname><given-names>C</given-names></name><name><surname>Genter</surname><given-names>P</given-names></name><name><surname>Gerstein</surname><given-names>HC</given-names></name><name><surname>Giedraitis</surname><given-names>V</given-names></name><name><surname>González-Villalpando</surname><given-names>C</given-names></name><name><surname>González-Villalpando</surname><given-names>ME</given-names></name><name><surname>Goodarzi</surname><given-names>MO</given-names></name><name><surname>Gordon-Larsen</surname><given-names>P</given-names></name><name><surname>Gorkin</surname><given-names>D</given-names></name><name><surname>Gross</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Hackinger</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>Herder</surname><given-names>C</given-names></name><name><surname>Howard</surname><given-names>AG</given-names></name><name><surname>Hsueh</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Hung</surname><given-names>YJ</given-names></name><name><surname>Hwang</surname><given-names>MY</given-names></name><name><surname>Hwu</surname><given-names>CM</given-names></name><name><surname>Ichihara</surname><given-names>S</given-names></name><name><surname>Ikram</surname><given-names>MA</given-names></name><name><surname>Ingelsson</surname><given-names>M</given-names></name><name><surname>Islam</surname><given-names>MT</given-names></name><name><surname>Isono</surname><given-names>M</given-names></name><name><surname>Jang</surname><given-names>HM</given-names></name><name><surname>Jasmine</surname><given-names>F</given-names></name><name><surname>Jiang</surname><given-names>G</given-names></name><name><surname>Jonas</surname><given-names>JB</given-names></name><name><surname>Jørgensen</surname><given-names>ME</given-names></name><name><surname>Jørgensen</surname><given-names>T</given-names></name><name><surname>Kamatani</surname><given-names>Y</given-names></name><name><surname>Kandeel</surname><given-names>FR</given-names></name><name><surname>Kasturiratne</surname><given-names>A</given-names></name><name><surname>Katsuya</surname><given-names>T</given-names></name><name><surname>Kaur</surname><given-names>V</given-names></name><name><surname>Kawaguchi</surname><given-names>T</given-names></name><name><surname>Keaton</surname><given-names>JM</given-names></name><name><surname>Kho</surname><given-names>AN</given-names></name><name><surname>Khor</surname><given-names>CC</given-names></name><name><surname>Kibriya</surname><given-names>MG</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Kohara</surname><given-names>K</given-names></name><name><surname>Kriebel</surname><given-names>J</given-names></name><name><surname>Kronenberg</surname><given-names>F</given-names></name><name><surname>Kuusisto</surname><given-names>J</given-names></name><name><surname>Läll</surname><given-names>K</given-names></name><name><surname>Lange</surname><given-names>LA</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Lee</surname><given-names>NR</given-names></name><name><surname>Leong</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Li-Gao</surname><given-names>R</given-names></name><name><surname>Ligthart</surname><given-names>S</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Linneberg</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>CT</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Locke</surname><given-names>AE</given-names></name><name><surname>Louie</surname><given-names>T</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Luk</surname><given-names>AO</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Lv</surname><given-names>J</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Mamakou</surname><given-names>V</given-names></name><name><surname>Mani</surname><given-names>KR</given-names></name><name><surname>Meitinger</surname><given-names>T</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Morris</surname><given-names>AD</given-names></name><name><surname>Nadkarni</surname><given-names>GN</given-names></name><name><surname>Nadler</surname><given-names>JL</given-names></name><name><surname>Nalls</surname><given-names>MA</given-names></name><name><surname>Nayak</surname><given-names>U</given-names></name><name><surname>Nongmaithem</surname><given-names>SS</given-names></name><name><surname>Ntalla</surname><given-names>I</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Orozco</surname><given-names>L</given-names></name><name><surname>Patel</surname><given-names>SR</given-names></name><name><surname>Pereira</surname><given-names>MA</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Pirie</surname><given-names>FJ</given-names></name><name><surname>Porneala</surname><given-names>B</given-names></name><name><surname>Prasad</surname><given-names>G</given-names></name><name><surname>Preissl</surname><given-names>S</given-names></name><name><surname>Rasmussen-Torvik</surname><given-names>LJ</given-names></name><name><surname>Reiner</surname><given-names>AP</given-names></name><name><surname>Roden</surname><given-names>M</given-names></name><name><surname>Rohde</surname><given-names>R</given-names></name><name><surname>Roll</surname><given-names>K</given-names></name><name><surname>Sabanayagam</surname><given-names>C</given-names></name><name><surname>Sander</surname><given-names>M</given-names></name><name><surname>Sandow</surname><given-names>K</given-names></name><name><surname>Sattar</surname><given-names>N</given-names></name><name><surname>Schönherr</surname><given-names>S</given-names></name><name><surname>Schurmann</surname><given-names>C</given-names></name><name><surname>Shahriar</surname><given-names>M</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Shin</surname><given-names>DM</given-names></name><name><surname>Shriner</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>JA</given-names></name><name><surname>So</surname><given-names>WY</given-names></name><name><surname>Stančáková</surname><given-names>A</given-names></name><name><surname>Stilp</surname><given-names>AM</given-names></name><name><surname>Strauch</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>KD</given-names></name><name><surname>Thorand</surname><given-names>B</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Tomlinson</surname><given-names>B</given-names></name><name><surname>Torres</surname><given-names>JM</given-names></name><name><surname>Tsai</surname><given-names>FJ</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Tusie-Luna</surname><given-names>T</given-names></name><name><surname>Udler</surname><given-names>MS</given-names></name><name><surname>Valladares-Salgado</surname><given-names>A</given-names></name><name><surname>van Dam</surname><given-names>RM</given-names></name><name><surname>van Klinken</surname><given-names>JB</given-names></name><name><surname>Varma</surname><given-names>R</given-names></name><name><surname>Vujkovic</surname><given-names>M</given-names></name><name><surname>Wacher-Rodarte</surname><given-names>N</given-names></name><name><surname>Wheeler</surname><given-names>E</given-names></name><name><surname>Whitsel</surname><given-names>EA</given-names></name><name><surname>Wickremasinghe</surname><given-names>AR</given-names></name><name><surname>van Dijk</surname><given-names>KW</given-names></name><name><surname>Witte</surname><given-names>DR</given-names></name><name><surname>Yajnik</surname><given-names>CS</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Yamauchi</surname><given-names>T</given-names></name><name><surname>Yengo</surname><given-names>L</given-names></name><name><surname>Yoon</surname><given-names>K</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Yuan</surname><given-names>JM</given-names></name><name><surname>Yusuf</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><collab>FinnGen</collab><collab>eMERGE Consortium</collab><name><surname>Raffel</surname><given-names>LJ</given-names></name><name><surname>Igase</surname><given-names>M</given-names></name><name><surname>Ipp</surname><given-names>E</given-names></name><name><surname>Redline</surname><given-names>S</given-names></name><name><surname>Cho</surname><given-names>YS</given-names></name><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Province</surname><given-names>MA</given-names></name><name><surname>Hanis</surname><given-names>CL</given-names></name><name><surname>Peyser</surname><given-names>PA</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Zonderman</surname><given-names>AB</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Wang</surname><given-names>YX</given-names></name><name><surname>Rotimi</surname><given-names>CN</given-names></name><name><surname>Becker</surname><given-names>DM</given-names></name><name><surname>Matsuda</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Yokota</surname><given-names>M</given-names></name><name><surname>Rich</surname><given-names>SS</given-names></name><name><surname>Kooperberg</surname><given-names>C</given-names></name><name><surname>Pankow</surname><given-names>JS</given-names></name><name><surname>Engert</surname><given-names>JC</given-names></name><name><surname>Chen</surname><given-names>YDI</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Wilson</surname><given-names>JG</given-names></name><name><surname>Sheu</surname><given-names>WHH</given-names></name><name><surname>Kardia</surname><given-names>SLR</given-names></name><name><surname>Wu</surname><given-names>JY</given-names></name><name><surname>Hayes</surname><given-names>MG</given-names></name><name><surname>Ma</surname><given-names>RCW</given-names></name><name><surname>Wong</surname><given-names>TY</given-names></name><name><surname>Groop</surname><given-names>L</given-names></name><name><surname>Mook-Kanamori</surname><given-names>DO</given-names></name><name><surname>Chandak</surname><given-names>GR</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Bharadwaj</surname><given-names>D</given-names></name><name><surname>Paré</surname><given-names>G</given-names></name><name><surname>Sale</surname><given-names>MM</given-names></name><name><surname>Ahsan</surname><given-names>H</given-names></name><name><surname>Motala</surname><given-names>AA</given-names></name><name><surname>Shu</surname><given-names>XO</given-names></name><name><surname>Park</surname><given-names>KS</given-names></name><name><surname>Jukema</surname><given-names>JW</given-names></name><name><surname>Cruz</surname><given-names>M</given-names></name><name><surname>McKean-Cowdin</surname><given-names>R</given-names></name><name><surname>Grallert</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>CY</given-names></name><name><surname>Bottinger</surname><given-names>EP</given-names></name><name><surname>Dehghan</surname><given-names>A</given-names></name><name><surname>Tai</surname><given-names>ES</given-names></name><name><surname>Dupuis</surname><given-names>J</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Köttgen</surname><given-names>A</given-names></name><name><surname>Koh</surname><given-names>WP</given-names></name><name><surname>Palmer</surname><given-names>CNA</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name><name><surname>Kooner</surname><given-names>JS</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>North</surname><given-names>KE</given-names></name><name><surname>Haiman</surname><given-names>CA</given-names></name><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Saleheen</surname><given-names>D</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Mägi</surname><given-names>R</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name><name><surname>Kadowaki</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Millwood</surname><given-names>IY</given-names></name><name><surname>Walters</surname><given-names>RG</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Myers</surname><given-names>SR</given-names></name><name><surname>Ferrer</surname><given-names>J</given-names></name><name><surname>Gaulton</surname><given-names>KJ</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Gloyn</surname><given-names>AL</given-names></name><name><surname>Bowden</surname><given-names>DW</given-names></name><name><surname>Below</surname><given-names>JE</given-names></name><name><surname>Chambers</surname><given-names>JC</given-names></name><name><surname>Sim</surname><given-names>X</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation</article-title><source>Nature Genetics</source><volume>54</volume><fpage>560</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1038/s41588-022-01058-3</pub-id><pub-id pub-id-type="pmid">35551307</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manolopoulos</surname><given-names>KN</given-names></name><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Frayn</surname><given-names>KN</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Gluteofemoral body fat as a determinant of metabolic health</article-title><source>International Journal of Obesity</source><volume>34</volume><fpage>949</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1038/ijo.2009.286</pub-id><pub-id pub-id-type="pmid">20065965</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>A</given-names></name><name><surname>Larsson</surname><given-names>SC</given-names></name><name><surname>Fall</surname><given-names>T</given-names></name><name><surname>Melhus</surname><given-names>H</given-names></name><name><surname>Michaëlsson</surname><given-names>K</given-names></name><name><surname>Byberg</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Fasting glucose, bone area and bone mineral density: A Mendelian randomisation study</article-title><source>Diabetologia</source><volume>64</volume><fpage>1348</fpage><lpage>1357</lpage><pub-id pub-id-type="doi">10.1007/s00125-021-05410-w</pub-id><pub-id pub-id-type="pmid">33650017</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Teslovich</surname><given-names>TM</given-names></name><name><surname>Ferreira</surname><given-names>T</given-names></name><name><surname>Segrè</surname><given-names>AV</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Strawbridge</surname><given-names>RJ</given-names></name><name><surname>Khan</surname><given-names>H</given-names></name><name><surname>Grallert</surname><given-names>H</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Prokopenko</surname><given-names>I</given-names></name><name><surname>Kang</surname><given-names>HM</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Fraser</surname><given-names>RM</given-names></name><name><surname>Kanoni</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Lagou</surname><given-names>V</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Müller-Nurasyid</surname><given-names>M</given-names></name><name><surname>Pechlivanis</surname><given-names>S</given-names></name><name><surname>Rayner</surname><given-names>NW</given-names></name><name><surname>Scott</surname><given-names>LJ</given-names></name><name><surname>Wiltshire</surname><given-names>S</given-names></name><name><surname>Yengo</surname><given-names>L</given-names></name><name><surname>Kinnunen</surname><given-names>L</given-names></name><name><surname>Rossin</surname><given-names>EJ</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>AD</given-names></name><name><surname>Dimas</surname><given-names>AS</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Vedantam</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Fox</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>CT</given-names></name><name><surname>Rybin</surname><given-names>D</given-names></name><name><surname>Couper</surname><given-names>DJ</given-names></name><name><surname>Kao</surname><given-names>WHL</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Cornelis</surname><given-names>MC</given-names></name><name><surname>Kraft</surname><given-names>P</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>van Dam</surname><given-names>RM</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Chines</surname><given-names>PS</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Fontanillas</surname><given-names>P</given-names></name><name><surname>Holmen</surname><given-names>OL</given-names></name><name><surname>Hunt</surname><given-names>SE</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Kong</surname><given-names>A</given-names></name><name><surname>Lawrence</surname><given-names>R</given-names></name><name><surname>Meyer</surname><given-names>J</given-names></name><name><surname>Perry</surname><given-names>JRB</given-names></name><name><surname>Platou</surname><given-names>CGP</given-names></name><name><surname>Potter</surname><given-names>S</given-names></name><name><surname>Rehnberg</surname><given-names>E</given-names></name><name><surname>Robertson</surname><given-names>N</given-names></name><name><surname>Sivapalaratnam</surname><given-names>S</given-names></name><name><surname>Stančáková</surname><given-names>A</given-names></name><name><surname>Stirrups</surname><given-names>K</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Tikkanen</surname><given-names>E</given-names></name><name><surname>Wood</surname><given-names>AR</given-names></name><name><surname>Almgren</surname><given-names>P</given-names></name><name><surname>Atalay</surname><given-names>M</given-names></name><name><surname>Benediktsson</surname><given-names>R</given-names></name><name><surname>Bonnycastle</surname><given-names>LL</given-names></name><name><surname>Burtt</surname><given-names>N</given-names></name><name><surname>Carey</surname><given-names>J</given-names></name><name><surname>Charpentier</surname><given-names>G</given-names></name><name><surname>Crenshaw</surname><given-names>AT</given-names></name><name><surname>Doney</surname><given-names>ASF</given-names></name><name><surname>Dorkhan</surname><given-names>M</given-names></name><name><surname>Edkins</surname><given-names>S</given-names></name><name><surname>Emilsson</surname><given-names>V</given-names></name><name><surname>Eury</surname><given-names>E</given-names></name><name><surname>Forsen</surname><given-names>T</given-names></name><name><surname>Gertow</surname><given-names>K</given-names></name><name><surname>Gigante</surname><given-names>B</given-names></name><name><surname>Grant</surname><given-names>GB</given-names></name><name><surname>Groves</surname><given-names>CJ</given-names></name><name><surname>Guiducci</surname><given-names>C</given-names></name><name><surname>Herder</surname><given-names>C</given-names></name><name><surname>Hreidarsson</surname><given-names>AB</given-names></name><name><surname>Hui</surname><given-names>J</given-names></name><name><surname>James</surname><given-names>A</given-names></name><name><surname>Jonsson</surname><given-names>A</given-names></name><name><surname>Rathmann</surname><given-names>W</given-names></name><name><surname>Klopp</surname><given-names>N</given-names></name><name><surname>Kravic</surname><given-names>J</given-names></name><name><surname>Krjutškov</surname><given-names>K</given-names></name><name><surname>Langford</surname><given-names>C</given-names></name><name><surname>Leander</surname><given-names>K</given-names></name><name><surname>Lindholm</surname><given-names>E</given-names></name><name><surname>Lobbens</surname><given-names>S</given-names></name><name><surname>Männistö</surname><given-names>S</given-names></name><name><surname>Mirza</surname><given-names>G</given-names></name><name><surname>Mühleisen</surname><given-names>TW</given-names></name><name><surname>Musk</surname><given-names>B</given-names></name><name><surname>Parkin</surname><given-names>M</given-names></name><name><surname>Rallidis</surname><given-names>L</given-names></name><name><surname>Saramies</surname><given-names>J</given-names></name><name><surname>Sennblad</surname><given-names>B</given-names></name><name><surname>Shah</surname><given-names>S</given-names></name><name><surname>Sigurðsson</surname><given-names>G</given-names></name><name><surname>Silveira</surname><given-names>A</given-names></name><name><surname>Steinbach</surname><given-names>G</given-names></name><name><surname>Thorand</surname><given-names>B</given-names></name><name><surname>Trakalo</surname><given-names>J</given-names></name><name><surname>Veglia</surname><given-names>F</given-names></name><name><surname>Wennauer</surname><given-names>R</given-names></name><name><surname>Winckler</surname><given-names>W</given-names></name><name><surname>Zabaneh</surname><given-names>D</given-names></name><name><surname>Campbell</surname><given-names>H</given-names></name><name><surname>van Duijn</surname><given-names>C</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Sijbrands</surname><given-names>E</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Owen</surname><given-names>KR</given-names></name><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Trip</surname><given-names>MD</given-names></name><name><surname>Forouhi</surname><given-names>NG</given-names></name><name><surname>Syvänen</surname><given-names>AC</given-names></name><name><surname>Eriksson</surname><given-names>JG</given-names></name><name><surname>Peltonen</surname><given-names>L</given-names></name><name><surname>Nöthen</surname><given-names>MM</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Palmer</surname><given-names>CNA</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Tuomi</surname><given-names>T</given-names></name><name><surname>Isomaa</surname><given-names>B</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Shuldiner</surname><given-names>AR</given-names></name><name><surname>Roden</surname><given-names>M</given-names></name><name><surname>Barroso</surname><given-names>I</given-names></name><name><surname>Wilsgaard</surname><given-names>T</given-names></name><name><surname>Beilby</surname><given-names>J</given-names></name><name><surname>Hovingh</surname><given-names>K</given-names></name><name><surname>Price</surname><given-names>JF</given-names></name><name><surname>Wilson</surname><given-names>JF</given-names></name><name><surname>Rauramaa</surname><given-names>R</given-names></name><name><surname>Lakka</surname><given-names>TA</given-names></name><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Dedoussis</surname><given-names>G</given-names></name><name><surname>Njølstad</surname><given-names>I</given-names></name><name><surname>Pedersen</surname><given-names>NL</given-names></name><name><surname>Khaw</surname><given-names>KT</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Keinanen-Kiukaanniemi</surname><given-names>SM</given-names></name><name><surname>Saaristo</surname><given-names>TE</given-names></name><name><surname>Korpi-Hyövälti</surname><given-names>E</given-names></name><name><surname>Saltevo</surname><given-names>J</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Kuusisto</surname><given-names>J</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Bergman</surname><given-names>RN</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Boehm</surname><given-names>BO</given-names></name><name><surname>Gieger</surname><given-names>C</given-names></name><name><surname>Hveem</surname><given-names>K</given-names></name><name><surname>Cauchi</surname><given-names>S</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Baldassarre</surname><given-names>D</given-names></name><name><surname>Tremoli</surname><given-names>E</given-names></name><name><surname>Humphries</surname><given-names>SE</given-names></name><name><surname>Saleheen</surname><given-names>D</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Ripatti</surname><given-names>S</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Erbel</surname><given-names>R</given-names></name><name><surname>Jöckel</surname><given-names>KH</given-names></name><name><surname>Moebus</surname><given-names>S</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>de Faire</surname><given-names>U</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><name><surname>Morris</surname><given-names>AD</given-names></name><name><surname>Donnelly</surname><given-names>PJ</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Nilsson</surname><given-names>PM</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Groop</surname><given-names>LC</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Hu</surname><given-names>F</given-names></name><name><surname>Pankow</surname><given-names>JS</given-names></name><name><surname>Dupuis</surname><given-names>J</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes</article-title><source>Nature Genetics</source><volume>44</volume><fpage>981</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.1038/ng.2383</pub-id><pub-id pub-id-type="pmid">22885922</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>JA</given-names></name><name><surname>Kemp</surname><given-names>JP</given-names></name><name><surname>Youlten</surname><given-names>SE</given-names></name><name><surname>Laurent</surname><given-names>L</given-names></name><name><surname>Logan</surname><given-names>JG</given-names></name><name><surname>Chai</surname><given-names>RC</given-names></name><name><surname>Vulpescu</surname><given-names>NA</given-names></name><name><surname>Forgetta</surname><given-names>V</given-names></name><name><surname>Kleinman</surname><given-names>A</given-names></name><name><surname>Mohanty</surname><given-names>ST</given-names></name><name><surname>Sergio</surname><given-names>CM</given-names></name><name><surname>Quinn</surname><given-names>J</given-names></name><name><surname>Nguyen-Yamamoto</surname><given-names>L</given-names></name><name><surname>Luco</surname><given-names>AL</given-names></name><name><surname>Vijay</surname><given-names>J</given-names></name><name><surname>Simon</surname><given-names>MM</given-names></name><name><surname>Pramatarova</surname><given-names>A</given-names></name><name><surname>Medina-Gomez</surname><given-names>C</given-names></name><name><surname>Trajanoska</surname><given-names>K</given-names></name><name><surname>Ghirardello</surname><given-names>EJ</given-names></name><name><surname>Butterfield</surname><given-names>NC</given-names></name><name><surname>Curry</surname><given-names>KF</given-names></name><name><surname>Leitch</surname><given-names>VD</given-names></name><name><surname>Sparkes</surname><given-names>PC</given-names></name><name><surname>Adoum</surname><given-names>AT</given-names></name><name><surname>Mannan</surname><given-names>NS</given-names></name><name><surname>Komla-Ebri</surname><given-names>DSK</given-names></name><name><surname>Pollard</surname><given-names>AS</given-names></name><name><surname>Dewhurst</surname><given-names>HF</given-names></name><name><surname>Hassall</surname><given-names>TAD</given-names></name><name><surname>Beltejar</surname><given-names>MJG</given-names></name><collab>23andMe Research Team</collab><name><surname>Adams</surname><given-names>DJ</given-names></name><name><surname>Vaillancourt</surname><given-names>SM</given-names></name><name><surname>Kaptoge</surname><given-names>S</given-names></name><name><surname>Baldock</surname><given-names>P</given-names></name><name><surname>Cooper</surname><given-names>C</given-names></name><name><surname>Reeve</surname><given-names>J</given-names></name><name><surname>Ntzani</surname><given-names>EE</given-names></name><name><surname>Evangelou</surname><given-names>E</given-names></name><name><surname>Ohlsson</surname><given-names>C</given-names></name><name><surname>Karasik</surname><given-names>D</given-names></name><name><surname>Rivadeneira</surname><given-names>F</given-names></name><name><surname>Kiel</surname><given-names>DP</given-names></name><name><surname>Tobias</surname><given-names>JH</given-names></name><name><surname>Gregson</surname><given-names>CL</given-names></name><name><surname>Harvey</surname><given-names>NC</given-names></name><name><surname>Grundberg</surname><given-names>E</given-names></name><name><surname>Goltzman</surname><given-names>D</given-names></name><name><surname>Adams</surname><given-names>DJ</given-names></name><name><surname>Lelliott</surname><given-names>CJ</given-names></name><name><surname>Hinds</surname><given-names>DA</given-names></name><name><surname>Ackert-Bicknell</surname><given-names>CL</given-names></name><name><surname>Hsu</surname><given-names>YH</given-names></name><name><surname>Maurano</surname><given-names>MT</given-names></name><name><surname>Croucher</surname><given-names>PI</given-names></name><name><surname>Williams</surname><given-names>GR</given-names></name><name><surname>Bassett</surname><given-names>JHD</given-names></name><name><surname>Evans</surname><given-names>DM</given-names></name><name><surname>Richards</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An atlas of genetic influences on osteoporosis in humans and mice</article-title><source>Nature Genetics</source><volume>51</volume><fpage>258</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0302-x</pub-id><pub-id pub-id-type="pmid">30598549</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Napoli</surname><given-names>N</given-names></name><name><surname>Strotmeyer</surname><given-names>ES</given-names></name><name><surname>Ensrud</surname><given-names>KE</given-names></name><name><surname>Sellmeyer</surname><given-names>DE</given-names></name><name><surname>Bauer</surname><given-names>DC</given-names></name><name><surname>Hoffman</surname><given-names>AR</given-names></name><name><surname>Dam</surname><given-names>TTL</given-names></name><name><surname>Barrett-Connor</surname><given-names>E</given-names></name><name><surname>Palermo</surname><given-names>L</given-names></name><name><surname>Orwoll</surname><given-names>ES</given-names></name><name><surname>Cummings</surname><given-names>SR</given-names></name><name><surname>Black</surname><given-names>DM</given-names></name><name><surname>Schwartz</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fracture risk in diabetic elderly men: the MrOS study</article-title><source>Diabetologia</source><volume>57</volume><fpage>2057</fpage><lpage>2065</lpage><pub-id pub-id-type="doi">10.1007/s00125-014-3289-6</pub-id><pub-id pub-id-type="pmid">24908567</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>KH</given-names></name><name><surname>Henning</surname><given-names>P</given-names></name><name><surname>El Shahawy</surname><given-names>M</given-names></name><name><surname>Nethander</surname><given-names>M</given-names></name><name><surname>Andersen</surname><given-names>TL</given-names></name><name><surname>Ejersted</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Gustafsson</surname><given-names>KL</given-names></name><name><surname>Koskela</surname><given-names>A</given-names></name><name><surname>Tuukkanen</surname><given-names>J</given-names></name><name><surname>Souza</surname><given-names>PPC</given-names></name><name><surname>Tuckermann</surname><given-names>J</given-names></name><name><surname>Lorentzon</surname><given-names>M</given-names></name><name><surname>Ruud</surname><given-names>LE</given-names></name><name><surname>Lehtimäki</surname><given-names>T</given-names></name><name><surname>Tobias</surname><given-names>JH</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Lerner</surname><given-names>UH</given-names></name><name><surname>Richards</surname><given-names>JB</given-names></name><name><surname>Movérare-Skrtic</surname><given-names>S</given-names></name><name><surname>Ohlsson</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>RSPO3 is important for trabecular bone and fracture risk in mice and humans</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>4923</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-25124-2</pub-id><pub-id pub-id-type="pmid">34389713</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osório</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>BMD and fracture risk in T2DM-clarifying a paradox</article-title><source>Nature Reviews. Endocrinology</source><volume>7</volume><elocation-id>376</elocation-id><pub-id pub-id-type="doi">10.1038/nrendo.2011.89</pub-id><pub-id pub-id-type="pmid">21610685</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>KQ</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>SY</given-names></name><name><surname>Chen</surname><given-names>GB</given-names></name><name><surname>Cong</surname><given-names>PK</given-names></name><name><surname>Khederzadeh</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>HF</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Observational and genetic evidence highlight the association of human sleep behaviors with the incidence of fracture</article-title><source>Communications Biology</source><volume>4</volume><elocation-id>1339</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-021-02861-0</pub-id><pub-id pub-id-type="pmid">34837057</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>JB</given-names></name><name><surname>Zheng</surname><given-names>HF</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Genetics of osteoporosis from genome-wide association studies: advances and challenges</article-title><source>Nature Reviews. Genetics</source><volume>13</volume><fpage>576</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1038/nrg3228</pub-id><pub-id pub-id-type="pmid">22805710</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero-Díaz</surname><given-names>C</given-names></name><name><surname>Duarte-Montero</surname><given-names>D</given-names></name><name><surname>Gutiérrez-Romero</surname><given-names>SA</given-names></name><name><surname>Mendivil</surname><given-names>CO</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Diabetes and bone fragility</article-title><source>Diabetes Therapy</source><volume>12</volume><fpage>71</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1007/s13300-020-00964-1</pub-id><pub-id pub-id-type="pmid">33185853</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanderson</surname><given-names>E</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Windmeijer</surname><given-names>F</given-names></name><name><surname>Bowden</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An examination of multivariable mendelian randomization in the single-sample and two-sample summary data settings</article-title><source>International Journal of Epidemiology</source><volume>48</volume><fpage>713</fpage><lpage>727</lpage><pub-id pub-id-type="doi">10.1093/ije/dyy262</pub-id><pub-id pub-id-type="pmid">30535378</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanderson</surname><given-names>E</given-names></name><name><surname>Spiller</surname><given-names>W</given-names></name><name><surname>Bowden</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021a</year><article-title>Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization</article-title><source>Statistics in Medicine</source><volume>40</volume><fpage>5434</fpage><lpage>5452</lpage><pub-id pub-id-type="doi">10.1002/sim.9133</pub-id><pub-id pub-id-type="pmid">34338327</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Sanderson</surname><given-names>E</given-names></name><name><surname>Spiller</surname><given-names>W</given-names></name><name><surname>Bowden</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021b</year><data-title>MVMR</data-title><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/WSpiller/MVMR">https://github.com/WSpiller/MVMR</ext-link></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>AV</given-names></name><name><surname>Hillier</surname><given-names>TA</given-names></name><name><surname>Sellmeyer</surname><given-names>DE</given-names></name><name><surname>Resnick</surname><given-names>HE</given-names></name><name><surname>Gregg</surname><given-names>E</given-names></name><name><surname>Ensrud</surname><given-names>KE</given-names></name><name><surname>Schreiner</surname><given-names>PJ</given-names></name><name><surname>Margolis</surname><given-names>KL</given-names></name><name><surname>Cauley</surname><given-names>JA</given-names></name><name><surname>Nevitt</surname><given-names>MC</given-names></name><name><surname>Black</surname><given-names>DM</given-names></name><name><surname>Cummings</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Older women with diabetes have a higher risk of falls: a prospective study</article-title><source>Diabetes Care</source><volume>25</volume><fpage>1749</fpage><lpage>1754</lpage><pub-id pub-id-type="doi">10.2337/diacare.25.10.1749</pub-id><pub-id pub-id-type="pmid">12351472</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>AV</given-names></name><name><surname>Vittinghoff</surname><given-names>E</given-names></name><name><surname>Bauer</surname><given-names>DC</given-names></name><name><surname>Hillier</surname><given-names>TA</given-names></name><name><surname>Strotmeyer</surname><given-names>ES</given-names></name><name><surname>Ensrud</surname><given-names>KE</given-names></name><name><surname>Donaldson</surname><given-names>MG</given-names></name><name><surname>Cauley</surname><given-names>JA</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Koster</surname><given-names>A</given-names></name><name><surname>Womack</surname><given-names>CR</given-names></name><name><surname>Palermo</surname><given-names>L</given-names></name><name><surname>Black</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes</article-title><source>JAMA</source><volume>305</volume><fpage>2184</fpage><lpage>2192</lpage><pub-id pub-id-type="doi">10.1001/jama.2011.715</pub-id><pub-id pub-id-type="pmid">21632482</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartzman</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The effect of correlation in false discovery rate estimation</article-title><source>Biometrika</source><volume>98</volume><fpage>199</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1093/biomet/asq075</pub-id><pub-id pub-id-type="pmid">23049127</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shungin</surname><given-names>D</given-names></name><name><surname>Winkler</surname><given-names>TW</given-names></name><name><surname>Croteau-Chonka</surname><given-names>DC</given-names></name><name><surname>Ferreira</surname><given-names>T</given-names></name><name><surname>Locke</surname><given-names>AE</given-names></name><name><surname>Mägi</surname><given-names>R</given-names></name><name><surname>Strawbridge</surname><given-names>RJ</given-names></name><name><surname>Pers</surname><given-names>TH</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Justice</surname><given-names>AE</given-names></name><name><surname>Workalemahu</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>JMW</given-names></name><name><surname>Buchkovich</surname><given-names>ML</given-names></name><name><surname>Heard-Costa</surname><given-names>NL</given-names></name><name><surname>Roman</surname><given-names>TS</given-names></name><name><surname>Drong</surname><given-names>AW</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Gustafsson</surname><given-names>S</given-names></name><name><surname>Day</surname><given-names>FR</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Fall</surname><given-names>T</given-names></name><name><surname>Kutalik</surname><given-names>Z</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Randall</surname><given-names>JC</given-names></name><name><surname>Scherag</surname><given-names>A</given-names></name><name><surname>Vedantam</surname><given-names>S</given-names></name><name><surname>Wood</surname><given-names>AR</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Fehrmann</surname><given-names>R</given-names></name><name><surname>Karjalainen</surname><given-names>J</given-names></name><name><surname>Kahali</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>CT</given-names></name><name><surname>Schmidt</surname><given-names>EM</given-names></name><name><surname>Absher</surname><given-names>D</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Anderson</surname><given-names>D</given-names></name><name><surname>Beekman</surname><given-names>M</given-names></name><name><surname>Bragg-Gresham</surname><given-names>JL</given-names></name><name><surname>Buyske</surname><given-names>S</given-names></name><name><surname>Demirkan</surname><given-names>A</given-names></name><name><surname>Ehret</surname><given-names>GB</given-names></name><name><surname>Feitosa</surname><given-names>MF</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Johnson</surname><given-names>T</given-names></name><name><surname>Kleber</surname><given-names>ME</given-names></name><name><surname>Kristiansson</surname><given-names>K</given-names></name><name><surname>Mangino</surname><given-names>M</given-names></name><name><surname>Leach</surname><given-names>IM</given-names></name><name><surname>Medina-Gomez</surname><given-names>C</given-names></name><name><surname>Palmer</surname><given-names>CD</given-names></name><name><surname>Pasko</surname><given-names>D</given-names></name><name><surname>Pechlivanis</surname><given-names>S</given-names></name><name><surname>Peters</surname><given-names>MJ</given-names></name><name><surname>Prokopenko</surname><given-names>I</given-names></name><name><surname>Stančáková</surname><given-names>A</given-names></name><name><surname>Sung</surname><given-names>YJ</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Van Vliet-Ostaptchouk</surname><given-names>JV</given-names></name><name><surname>Yengo</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Albrecht</surname><given-names>E</given-names></name><name><surname>Ärnlöv</surname><given-names>J</given-names></name><name><surname>Arscott</surname><given-names>GM</given-names></name><name><surname>Bandinelli</surname><given-names>S</given-names></name><name><surname>Barrett</surname><given-names>A</given-names></name><name><surname>Bellis</surname><given-names>C</given-names></name><name><surname>Bennett</surname><given-names>AJ</given-names></name><name><surname>Berne</surname><given-names>C</given-names></name><name><surname>Blüher</surname><given-names>M</given-names></name><name><surname>Böhringer</surname><given-names>S</given-names></name><name><surname>Bonnet</surname><given-names>F</given-names></name><name><surname>Böttcher</surname><given-names>Y</given-names></name><name><surname>Bruinenberg</surname><given-names>M</given-names></name><name><surname>Carba</surname><given-names>DB</given-names></name><name><surname>Caspersen</surname><given-names>IH</given-names></name><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Daw</surname><given-names>EW</given-names></name><name><surname>Deelen</surname><given-names>J</given-names></name><name><surname>Deelman</surname><given-names>E</given-names></name><name><surname>Delgado</surname><given-names>G</given-names></name><name><surname>Doney</surname><given-names>AS</given-names></name><name><surname>Eklund</surname><given-names>N</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Estrada</surname><given-names>K</given-names></name><name><surname>Eury</surname><given-names>E</given-names></name><name><surname>Friedrich</surname><given-names>N</given-names></name><name><surname>Garcia</surname><given-names>ME</given-names></name><name><surname>Giedraitis</surname><given-names>V</given-names></name><name><surname>Gigante</surname><given-names>B</given-names></name><name><surname>Go</surname><given-names>AS</given-names></name><name><surname>Golay</surname><given-names>A</given-names></name><name><surname>Grallert</surname><given-names>H</given-names></name><name><surname>Grammer</surname><given-names>TB</given-names></name><name><surname>Gräßler</surname><given-names>J</given-names></name><name><surname>Grewal</surname><given-names>J</given-names></name><name><surname>Groves</surname><given-names>CJ</given-names></name><name><surname>Haller</surname><given-names>T</given-names></name><name><surname>Hallmans</surname><given-names>G</given-names></name><name><surname>Hartman</surname><given-names>CA</given-names></name><name><surname>Hassinen</surname><given-names>M</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Heikkilä</surname><given-names>K</given-names></name><name><surname>Herzig</surname><given-names>KH</given-names></name><name><surname>Helmer</surname><given-names>Q</given-names></name><name><surname>Hillege</surname><given-names>HL</given-names></name><name><surname>Holmen</surname><given-names>O</given-names></name><name><surname>Hunt</surname><given-names>SC</given-names></name><name><surname>Isaacs</surname><given-names>A</given-names></name><name><surname>Ittermann</surname><given-names>T</given-names></name><name><surname>James</surname><given-names>AL</given-names></name><name><surname>Johansson</surname><given-names>I</given-names></name><name><surname>Juliusdottir</surname><given-names>T</given-names></name><name><surname>Kalafati</surname><given-names>IP</given-names></name><name><surname>Kinnunen</surname><given-names>L</given-names></name><name><surname>Koenig</surname><given-names>W</given-names></name><name><surname>Kooner</surname><given-names>IK</given-names></name><name><surname>Kratzer</surname><given-names>W</given-names></name><name><surname>Lamina</surname><given-names>C</given-names></name><name><surname>Leander</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>NR</given-names></name><name><surname>Lichtner</surname><given-names>P</given-names></name><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Lindström</surname><given-names>J</given-names></name><name><surname>Lobbens</surname><given-names>S</given-names></name><name><surname>Lorentzon</surname><given-names>M</given-names></name><name><surname>Mach</surname><given-names>F</given-names></name><name><surname>Magnusson</surname><given-names>PK</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>McArdle</surname><given-names>WL</given-names></name><name><surname>Menni</surname><given-names>C</given-names></name><name><surname>Merger</surname><given-names>S</given-names></name><name><surname>Mihailov</surname><given-names>E</given-names></name><name><surname>Milani</surname><given-names>L</given-names></name><name><surname>Mills</surname><given-names>R</given-names></name><name><surname>Moayyeri</surname><given-names>A</given-names></name><name><surname>Monda</surname><given-names>KL</given-names></name><name><surname>Mooijaart</surname><given-names>SP</given-names></name><name><surname>Mühleisen</surname><given-names>TW</given-names></name><name><surname>Mulas</surname><given-names>A</given-names></name><name><surname>Müller</surname><given-names>G</given-names></name><name><surname>Müller-Nurasyid</surname><given-names>M</given-names></name><name><surname>Nagaraja</surname><given-names>R</given-names></name><name><surname>Nalls</surname><given-names>MA</given-names></name><name><surname>Narisu</surname><given-names>N</given-names></name><name><surname>Glorioso</surname><given-names>N</given-names></name><name><surname>Nolte</surname><given-names>IM</given-names></name><name><surname>Olden</surname><given-names>M</given-names></name><name><surname>Rayner</surname><given-names>NW</given-names></name><name><surname>Renstrom</surname><given-names>F</given-names></name><name><surname>Ried</surname><given-names>JS</given-names></name><name><surname>Robertson</surname><given-names>NR</given-names></name><name><surname>Rose</surname><given-names>LM</given-names></name><name><surname>Sanna</surname><given-names>S</given-names></name><name><surname>Scharnagl</surname><given-names>H</given-names></name><name><surname>Scholtens</surname><given-names>S</given-names></name><name><surname>Sennblad</surname><given-names>B</given-names></name><name><surname>Seufferlein</surname><given-names>T</given-names></name><name><surname>Sitlani</surname><given-names>CM</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Stirrups</surname><given-names>K</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Sundström</surname><given-names>J</given-names></name><name><surname>Swertz</surname><given-names>MA</given-names></name><name><surname>Swift</surname><given-names>AJ</given-names></name><name><surname>Syvänen</surname><given-names>AC</given-names></name><name><surname>Tayo</surname><given-names>BO</given-names></name><name><surname>Thorand</surname><given-names>B</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Tomaschitz</surname><given-names>A</given-names></name><name><surname>Troffa</surname><given-names>C</given-names></name><name><surname>van Oort</surname><given-names>FV</given-names></name><name><surname>Verweij</surname><given-names>N</given-names></name><name><surname>Vonk</surname><given-names>JM</given-names></name><name><surname>Waite</surname><given-names>LL</given-names></name><name><surname>Wennauer</surname><given-names>R</given-names></name><name><surname>Wilsgaard</surname><given-names>T</given-names></name><name><surname>Wojczynski</surname><given-names>MK</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Zhao</surname><given-names>JH</given-names></name><name><surname>Brennan</surname><given-names>EP</given-names></name><name><surname>Choi</surname><given-names>M</given-names></name><name><surname>Eriksson</surname><given-names>P</given-names></name><name><surname>Folkersen</surname><given-names>L</given-names></name><name><surname>Franco-Cereceda</surname><given-names>A</given-names></name><name><surname>Gharavi</surname><given-names>AG</given-names></name><name><surname>Hedman</surname><given-names>ÅK</given-names></name><name><surname>Hivert</surname><given-names>MF</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Kanoni</surname><given-names>S</given-names></name><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Keildson</surname><given-names>S</given-names></name><name><surname>Kiryluk</surname><given-names>K</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Lifton</surname><given-names>RP</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name><name><surname>McKnight</surname><given-names>AJ</given-names></name><name><surname>McPherson</surname><given-names>R</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Min</surname><given-names>JL</given-names></name><name><surname>Moffatt</surname><given-names>MF</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Murabito</surname><given-names>JM</given-names></name><name><surname>Nicholson</surname><given-names>G</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name><name><surname>Olsson</surname><given-names>C</given-names></name><name><surname>Perry</surname><given-names>JR</given-names></name><name><surname>Reinmaa</surname><given-names>E</given-names></name><name><surname>Salem</surname><given-names>RM</given-names></name><name><surname>Sandholm</surname><given-names>N</given-names></name><name><surname>Schadt</surname><given-names>EE</given-names></name><name><surname>Scott</surname><given-names>RA</given-names></name><name><surname>Stolk</surname><given-names>L</given-names></name><name><surname>Vallejo</surname><given-names>EE</given-names></name><name><surname>Westra</surname><given-names>HJ</given-names></name><name><surname>Zondervan</surname><given-names>KT</given-names></name><name><surname>Arveiler</surname><given-names>D</given-names></name><name><surname>Bakker</surname><given-names>SJ</given-names></name><name><surname>Beilby</surname><given-names>J</given-names></name><name><surname>Bergman</surname><given-names>RN</given-names></name><name><surname>Blangero</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>MJ</given-names></name><name><surname>Burnier</surname><given-names>M</given-names></name><name><surname>Campbell</surname><given-names>H</given-names></name><name><surname>Chakravarti</surname><given-names>A</given-names></name><name><surname>Chines</surname><given-names>PS</given-names></name><name><surname>Claudi-Boehm</surname><given-names>S</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Crawford</surname><given-names>DC</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>de Faire</surname><given-names>U</given-names></name><name><surname>de Geus</surname><given-names>EJ</given-names></name><name><surname>Dörr</surname><given-names>M</given-names></name><name><surname>Erbel</surname><given-names>R</given-names></name><name><surname>Eriksson</surname><given-names>JG</given-names></name><name><surname>Farrall</surname><given-names>M</given-names></name><name><surname>Ferrannini</surname><given-names>E</given-names></name><name><surname>Ferrières</surname><given-names>J</given-names></name><name><surname>Forouhi</surname><given-names>NG</given-names></name><name><surname>Forrester</surname><given-names>T</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><name><surname>Gansevoort</surname><given-names>RT</given-names></name><name><surname>Gieger</surname><given-names>C</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Haiman</surname><given-names>CA</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>Heliövaara</surname><given-names>M</given-names></name><name><surname>Hicks</surname><given-names>AA</given-names></name><name><surname>Hingorani</surname><given-names>AD</given-names></name><name><surname>Hoffmann</surname><given-names>W</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Homuth</surname><given-names>G</given-names></name><name><surname>Humphries</surname><given-names>SE</given-names></name><name><surname>Hyppönen</surname><given-names>E</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>Jarvelin</surname><given-names>MR</given-names></name><name><surname>Johansen</surname><given-names>B</given-names></name><name><surname>Jousilahti</surname><given-names>P</given-names></name><name><surname>Jula</surname><given-names>AM</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Kee</surname><given-names>F</given-names></name><name><surname>Keinanen-Kiukaanniemi</surname><given-names>SM</given-names></name><name><surname>Kooner</surname><given-names>JS</given-names></name><name><surname>Kooperberg</surname><given-names>C</given-names></name><name><surname>Kovacs</surname><given-names>P</given-names></name><name><surname>Kraja</surname><given-names>AT</given-names></name><name><surname>Kumari</surname><given-names>M</given-names></name><name><surname>Kuulasmaa</surname><given-names>K</given-names></name><name><surname>Kuusisto</surname><given-names>J</given-names></name><name><surname>Lakka</surname><given-names>TA</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Le Marchand</surname><given-names>L</given-names></name><name><surname>Lehtimäki</surname><given-names>T</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Männistö</surname><given-names>S</given-names></name><name><surname>Marette</surname><given-names>A</given-names></name><name><surname>Matise</surname><given-names>TC</given-names></name><name><surname>McKenzie</surname><given-names>CA</given-names></name><name><surname>McKnight</surname><given-names>B</given-names></name><name><surname>Musk</surname><given-names>AW</given-names></name><name><surname>Möhlenkamp</surname><given-names>S</given-names></name><name><surname>Morris</surname><given-names>AD</given-names></name><name><surname>Nelis</surname><given-names>M</given-names></name><name><surname>Ohlsson</surname><given-names>C</given-names></name><name><surname>Oldehinkel</surname><given-names>AJ</given-names></name><name><surname>Ong</surname><given-names>KK</given-names></name><name><surname>Palmer</surname><given-names>LJ</given-names></name><name><surname>Penninx</surname><given-names>BW</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Pramstaller</surname><given-names>PP</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Rankinen</surname><given-names>T</given-names></name><name><surname>Rao</surname><given-names>DC</given-names></name><name><surname>Rice</surname><given-names>TK</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Ritchie</surname><given-names>MD</given-names></name><name><surname>Rudan</surname><given-names>I</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Samani</surname><given-names>NJ</given-names></name><name><surname>Saramies</surname><given-names>J</given-names></name><name><surname>Sarzynski</surname><given-names>MA</given-names></name><name><surname>Schwarz</surname><given-names>PE</given-names></name><name><surname>Shuldiner</surname><given-names>AR</given-names></name><name><surname>Staessen</surname><given-names>JA</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Stolk</surname><given-names>RP</given-names></name><name><surname>Strauch</surname><given-names>K</given-names></name><name><surname>Tönjes</surname><given-names>A</given-names></name><name><surname>Tremblay</surname><given-names>A</given-names></name><name><surname>Tremoli</surname><given-names>E</given-names></name><name><surname>Vohl</surname><given-names>MC</given-names></name><name><surname>Völker</surname><given-names>U</given-names></name><name><surname>Vollenweider</surname><given-names>P</given-names></name><name><surname>Wilson</surname><given-names>JF</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Adair</surname><given-names>LS</given-names></name><name><surname>Bochud</surname><given-names>M</given-names></name><name><surname>Boehm</surname><given-names>BO</given-names></name><name><surname>Bornstein</surname><given-names>SR</given-names></name><name><surname>Bouchard</surname><given-names>C</given-names></name><name><surname>Cauchi</surname><given-names>S</given-names></name><name><surname>Caulfield</surname><given-names>MJ</given-names></name><name><surname>Chambers</surname><given-names>JC</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Cooper</surname><given-names>RS</given-names></name><name><surname>Dedoussis</surname><given-names>G</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Grabe</surname><given-names>HJ</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><name><surname>Hui</surname><given-names>J</given-names></name><name><surname>Hveem</surname><given-names>K</given-names></name><name><surname>Jöckel</surname><given-names>KH</given-names></name><name><surname>Kivimaki</surname><given-names>M</given-names></name><name><surname>Kuh</surname><given-names>D</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>März</surname><given-names>W</given-names></name><name><surname>Munroe</surname><given-names>PB</given-names></name><name><surname>Njølstad</surname><given-names>I</given-names></name><name><surname>Oostra</surname><given-names>BA</given-names></name><name><surname>Palmer</surname><given-names>CN</given-names></name><name><surname>Pedersen</surname><given-names>NL</given-names></name><name><surname>Perola</surname><given-names>M</given-names></name><name><surname>Pérusse</surname><given-names>L</given-names></name><name><surname>Peters</surname><given-names>U</given-names></name><name><surname>Power</surname><given-names>C</given-names></name><name><surname>Quertermous</surname><given-names>T</given-names></name><name><surname>Rauramaa</surname><given-names>R</given-names></name><name><surname>Rivadeneira</surname><given-names>F</given-names></name><name><surname>Saaristo</surname><given-names>TE</given-names></name><name><surname>Saleheen</surname><given-names>D</given-names></name><name><surname>Sinisalo</surname><given-names>J</given-names></name><name><surname>Slagboom</surname><given-names>PE</given-names></name><name><surname>Snieder</surname><given-names>H</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Stumvoll</surname><given-names>M</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Uusitupa</surname><given-names>M</given-names></name><name><surname>van der Harst</surname><given-names>P</given-names></name><name><surname>Veronesi</surname><given-names>G</given-names></name><name><surname>Walker</surname><given-names>M</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Watkins</surname><given-names>H</given-names></name><name><surname>Wichmann</surname><given-names>HE</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Assimes</surname><given-names>TL</given-names></name><name><surname>Berndt</surname><given-names>SI</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Borecki</surname><given-names>IB</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Franke</surname><given-names>L</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Groop</surname><given-names>LC</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Kaplan</surname><given-names>RC</given-names></name><name><surname>O’Connell</surname><given-names>JR</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Schlessinger</surname><given-names>D</given-names></name><name><surname>Strachan</surname><given-names>DP</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Zillikens</surname><given-names>MC</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Speliotes</surname><given-names>EK</given-names></name><name><surname>North</surname><given-names>KE</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Barroso</surname><given-names>I</given-names></name><name><surname>Franks</surname><given-names>PW</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Heid</surname><given-names>IM</given-names></name><name><surname>Loos</surname><given-names>RJ</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>New genetic loci link adipose and insulin biology to body fat distribution</article-title><source>Nature</source><volume>518</volume><fpage>187</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1038/nature14132</pub-id><pub-id pub-id-type="pmid">25673412</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>BB</given-names></name><name><surname>Maranville</surname><given-names>JC</given-names></name><name><surname>Peters</surname><given-names>JE</given-names></name><name><surname>Stacey</surname><given-names>D</given-names></name><name><surname>Staley</surname><given-names>JR</given-names></name><name><surname>Blackshaw</surname><given-names>J</given-names></name><name><surname>Burgess</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Paige</surname><given-names>E</given-names></name><name><surname>Surendran</surname><given-names>P</given-names></name><name><surname>Oliver-Williams</surname><given-names>C</given-names></name><name><surname>Kamat</surname><given-names>MA</given-names></name><name><surname>Prins</surname><given-names>BP</given-names></name><name><surname>Wilcox</surname><given-names>SK</given-names></name><name><surname>Zimmerman</surname><given-names>ES</given-names></name><name><surname>Chi</surname><given-names>A</given-names></name><name><surname>Bansal</surname><given-names>N</given-names></name><name><surname>Spain</surname><given-names>SL</given-names></name><name><surname>Wood</surname><given-names>AM</given-names></name><name><surname>Morrell</surname><given-names>NW</given-names></name><name><surname>Bradley</surname><given-names>JR</given-names></name><name><surname>Janjic</surname><given-names>N</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><name><surname>Ouwehand</surname><given-names>WH</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name><name><surname>Suhre</surname><given-names>K</given-names></name><name><surname>Paul</surname><given-names>DS</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Plenge</surname><given-names>RM</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Runz</surname><given-names>H</given-names></name><name><surname>Butterworth</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genomic atlas of the human plasma proteome</article-title><source>Nature</source><volume>558</volume><fpage>73</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0175-2</pub-id><pub-id pub-id-type="pmid">29875488</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teck</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Diabetes-associated comorbidities</article-title><source>Primary Care</source><volume>49</volume><fpage>275</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1016/j.pop.2021.11.004</pub-id><pub-id pub-id-type="pmid">35595482</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tinajero</surname><given-names>MG</given-names></name><name><surname>Malik</surname><given-names>VS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>An update on the epidemiology of type 2 diabetes: A global perspective</article-title><source>Endocrinology and Metabolism Clinics of North America</source><volume>50</volume><fpage>337</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1016/j.ecl.2021.05.013</pub-id><pub-id pub-id-type="pmid">34399949</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trajanoska</surname><given-names>K</given-names></name><name><surname>Morris</surname><given-names>JA</given-names></name><name><surname>Oei</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>HF</given-names></name><name><surname>Evans</surname><given-names>DM</given-names></name><name><surname>Kiel</surname><given-names>DP</given-names></name><name><surname>Ohlsson</surname><given-names>C</given-names></name><name><surname>Richards</surname><given-names>JB</given-names></name><name><surname>Rivadeneira</surname><given-names>F</given-names></name><collab>GEFOS/GENOMOS consortium and the 23andMe research team</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study</article-title><source>BMJ</source><volume>362</volume><elocation-id>k3225</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.k3225</pub-id><pub-id pub-id-type="pmid">30158200</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verbanck</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Do</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases</article-title><source>Nature Genetics</source><volume>50</volume><fpage>693</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0099-7</pub-id><pub-id pub-id-type="pmid">29686387</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>SY</given-names></name><name><surname>Liu</surname><given-names>KQ</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>PP</given-names></name><name><surname>Gai</surname><given-names>SR</given-names></name><name><surname>Guan</surname><given-names>PL</given-names></name><name><surname>Zhao</surname><given-names>JQ</given-names></name><name><surname>Zhu</surname><given-names>YP</given-names></name><name><surname>Tsoi</surname><given-names>LC</given-names></name><name><surname>Stuart</surname><given-names>PE</given-names></name><name><surname>Nair</surname><given-names>RP</given-names></name><name><surname>Yang</surname><given-names>HQ</given-names></name><name><surname>Liao</surname><given-names>YT</given-names></name><name><surname>Mao</surname><given-names>K</given-names></name><name><surname>Qiu</surname><given-names>MC</given-names></name><name><surname>Ying</surname><given-names>ZM</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>ZH</given-names></name><name><surname>Bai</surname><given-names>WY</given-names></name><name><surname>Zhu</surname><given-names>XW</given-names></name><name><surname>Cong</surname><given-names>PK</given-names></name><name><surname>Elder</surname><given-names>JT</given-names></name><name><surname>Ye</surname><given-names>ZM</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>HF</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and mendelian randomisation study</article-title><source>Annals of the Rheumatic Diseases</source><volume>79</volume><fpage>1460</fpage><lpage>1467</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2020-217892</pub-id><pub-id pub-id-type="pmid">32737104</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>JW</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>CD</given-names></name><name><surname>Zhu</surname><given-names>XW</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Khederzadeh</surname><given-names>S</given-names></name><name><surname>Gu</surname><given-names>JX</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>JH</given-names></name><name><surname>Liu</surname><given-names>KQ</given-names></name><name><surname>Karasik</surname><given-names>D</given-names></name><name><surname>Xie</surname><given-names>SY</given-names></name><name><surname>Chen</surname><given-names>GB</given-names></name><name><surname>Zheng</surname><given-names>HF</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Both indirect maternal and direct fetal genetic effects reflect the observational relationship between higher birth weight and lower adult bone mass</article-title><source>BMC Medicine</source><volume>20</volume><elocation-id>361</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-022-02531-w</pub-id><pub-id pub-id-type="pmid">36192722</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yavorska</surname><given-names>OO</given-names></name><name><surname>Burgess</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mendelianrandomization: an r package for performing mendelian randomization analyses using summarized data</article-title><source>International Journal of Epidemiology</source><volume>46</volume><fpage>1734</fpage><lpage>1739</lpage><pub-id pub-id-type="doi">10.1093/ije/dyx034</pub-id><pub-id pub-id-type="pmid">28398548</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>PP</given-names></name><name><surname>Xu</surname><given-names>LW</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>YY</given-names></name><name><surname>Zhu</surname><given-names>XW</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>YC</given-names></name><name><surname>Zhao</surname><given-names>TT</given-names></name><name><surname>Wu</surname><given-names>TT</given-names></name><name><surname>Ma</surname><given-names>HY</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>XW</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>HF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Relationship between alcohol use, blood pressure and hypertension: an association study and a mendelian randomisation study</article-title><source>Journal of Epidemiology and Community Health</source><volume>73</volume><fpage>796</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1136/jech-2018-211185</pub-id><pub-id pub-id-type="pmid">31227586</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>ZN</given-names></name><name><surname>Jiang</surname><given-names>YF</given-names></name><name><surname>Ding</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials</article-title><source>Bone</source><volume>68</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2014.08.010</pub-id><pub-id pub-id-type="pmid">25173606</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Bakshi</surname><given-names>A</given-names></name><name><surname>Robinson</surname><given-names>MR</given-names></name><name><surname>Powell</surname><given-names>JE</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Goddard</surname><given-names>ME</given-names></name><name><surname>Wray</surname><given-names>NR</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets</article-title><source>Nature Genetics</source><volume>48</volume><fpage>481</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1038/ng.3538</pub-id><pub-id pub-id-type="pmid">27019110</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Twelve years of GWAS discoveries for osteoporosis and related traits: advances, challenges and applications</article-title><source>Bone Research</source><volume>9</volume><elocation-id>23</elocation-id><pub-id pub-id-type="doi">10.1038/s41413-021-00143-3</pub-id><pub-id pub-id-type="pmid">33927194</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Factors influencing peak bone mass gain</article-title><source>Frontiers of Medicine</source><volume>15</volume><fpage>53</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1007/s11684-020-0748-y</pub-id><pub-id pub-id-type="pmid">32519297</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>XW</given-names></name><name><surname>Liu</surname><given-names>KQ</given-names></name><name><surname>Yuan</surname><given-names>CD</given-names></name><name><surname>Xia</surname><given-names>JW</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>JH</given-names></name><name><surname>Rong</surname><given-names>XL</given-names></name><name><surname>Chen</surname><given-names>GB</given-names></name><name><surname>Karasik</surname><given-names>D</given-names></name><name><surname>Xie</surname><given-names>SY</given-names></name><name><surname>Zheng</surname><given-names>HF</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>General and abdominal obesity operate differently as influencing factors of fracture risk in old adults</article-title><source>iScience</source><volume>25</volume><elocation-id>104466</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2022.104466</pub-id><pub-id pub-id-type="pmid">35677640</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89281.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Se-Min</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Icahn School of Medicine at Mount Sinai</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Incomplete</kwd><kwd>Solid</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>This study aims to explore the diabetes-bone paradox using the Mendelian Randomization approach. That diabetes itself is not the direct cause, but rather the complications or associated risk factors increase the risk of fracture, constitutes a <bold>valuable</bold> insight. Mendelian randomization to explain the relationship of two complex conditions is <bold>solid</bold> and conducted properly; however, the efforts to reconcile the discrepancies between the Mendelian Randomization analysis and observational studies are <bold>incomplete</bold>.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89281.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The manuscript of Zhao et al. aimed at investigating the relationships between type 2 diabetes, bone mineral density (BMD) and fracture risk using Mendelian Randomization (MR) approach.</p><p>The authors found that genetically predicted T2D was associated with higher BMD and lower risk of fracture, and suggested a mediated effect of RSPO3 level. Moreover, when stratified by the risk factors secondary to T2D, they observed that the effect of T2D on the risk of fracture decreased when the number of risk factors secondary to T2D decreased.</p><p>Strengths:</p><p>- Important question</p><p>- Manuscript is overall clear and well-written</p><p>- MR analyses have been conducted properly, which include the usage of various MR methods and sensitivity analyses, and likely meet the criteria of the MR-strobe checklist to report MR results.</p><p>Weaknesses:</p><p>- Interpretation of MR findings should be more nuanced given the modest (almost neutral) relationship between T2D and fracture risk in MR</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89281.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The authors employed the Mendelian Randomization method to analyze the association between type 2 diabetes (T2D) and fracture using the UK Biobank data. They found that &quot;genetically predicted T2D was associated with higher BMD and lower risk of fracture&quot;. Additionally, they identified 10 loci that were associated with both T2D and fracture risk, with the SNP rs4580892 showing the highest signal. While the negative relationship between T2D and fracture has been previously observed, the discovery of these 10 loci adds an intriguing dimension to the findings, although the clinical implications remain uncertain.</p><p>Many thanks for your response which has clarified my understanding of your paper. And, thank you for the additional analyses. I still find the paper challenging to understand due to two different analyses that yielded conflicting results: (a) in the observational analysis, the authors found that type 2 diabetes was associated with both higher BMD and a higher risk of fracture (ie a paradox); but (b) in the Mendelian randomization analysis, 'genetically predicted type 2 diabetes' was associated with greater BMD and a lower risk of fracture. I consider that your conclusion is not consistent with the data you presented.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89281.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Pianpian</given-names></name><role specific-use="author">Author</role><aff><institution>Zhejiang University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Sheng</surname><given-names>Zhi-Feng</given-names></name><role specific-use="author">Author</role><aff><institution>The Second Xiangya Hospital of Central South University</institution><addr-line><named-content content-type="city">Changsha</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Lin</given-names></name><role specific-use="author">Author</role><aff><institution>Yantai Affiliated Hospital of Binzhou Medical University</institution><addr-line><named-content content-type="city">Yantai</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Peng</given-names></name><role specific-use="author">Author</role><aff><institution>The Third People's Hospital of Hangzhou</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xiao</surname><given-names>Wen-Jin</given-names></name><role specific-use="author">Author</role><aff><institution>Second Affiliated Hospital of Soochow University</institution><addr-line><named-content content-type="city">Suzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Cheng-Da</given-names></name><role specific-use="author">Author</role><aff><institution>Hangzhou Hospital of Traditional Chinese Medicine</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Zhanwei</given-names></name><role specific-use="author">Author</role><aff><institution>Central Health Center of Mashenqiao Town</institution><addr-line><named-content content-type="city">Tianjin</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Meng-Yuan</given-names></name><role specific-use="author">Author</role><aff><institution>Westlake University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Qian</surname><given-names>Yu</given-names></name><role specific-use="author">Author</role><aff><institution>Westlake University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhong</surname><given-names>Jia-Dong</given-names></name><role specific-use="author">Author</role><aff><institution>Westlake University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhong</surname><given-names>Jiaxuan</given-names></name><role specific-use="author">Author</role><aff><institution>Westlake University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Karasik</surname><given-names>David</given-names></name><role specific-use="author">Author</role><aff><institution>Bar Ilan University</institution><addr-line><named-content content-type="city">Safed</named-content></addr-line><country>Israel</country></aff></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Hou-Feng</given-names></name><role specific-use="author">Author</role><aff><institution>Westlake University</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public review):</bold></p><p>Summary:</p><p>The manuscript of Zhao et al. aimed at investigating the relationships between type 2 diabetes, bone mineral density (BMD) and fracture risk using Mendelian Randomization (MR) approach.</p><p>The authors found that genetically predicted T2D was associated with higher BMD and lower risk of fracture, and suggested a mediated effect of RSPO3 level. Moreover, when stratified by the risk factors secondary to T2D, they observed that the effect of T2D on the risk of fracture decreased when the number of risk factors secondary to T2D decreased.</p><p>Strengths:</p><list list-type="bullet"><list-item><p>Important question</p></list-item></list><list list-type="bullet"><list-item><p>Manuscript is overall clear and well-written</p></list-item></list><list list-type="bullet"><list-item><p>MR analyses have been conducted properly, which include the usage of various MR methods and sensitivity analyses, and likely meet the criteria of the MR-strobe checklist to report MR results.</p></list-item></list></disp-quote><p>Response: Thanks.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><list list-type="bullet"><list-item><p>Previous MR studies on that topic have not been discussed</p></list-item></list></disp-quote><p>Response: In the manuscript, we discussed the previous MR findings from Trajanoska et al., BMJ, 2018. This study assessed the effect of 15 clinical risk factors (including type 2 diabetes) on fracture risk. Now we have included the other two studies (Mitchell et al, Diabetologia, 2021; Ahmad et al JBMR, 2016) which took BMD as the exposure in the paragraph when we discussed the effects on BMD.</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>Multivariable MR could have been used to better assessed the mediative effect of BMI or RSPO3 on the relationships between T2D and fracture risk.</p></list-item></list></disp-quote><p>Response: In revision, the inverse weighted multivariable MR model was used to estimate the direct effect of T2D upon the fracture and BMD adjusted for BMI with ‘MVMR’ R package (<ext-link ext-link-type="uri" xlink:href="https://github.com/WSpiller/MVMR">https://github.com/WSpiller/MVMR</ext-link>). Specifically, we first extracted the overlapping SNPs from the summary data for T2D, BMI and fracture. Then the independent significant SNPs (P&lt;5×10−8 and R2&lt;0.1) for either T2D or BMI were pooled as instruments. Additionally, we performed SNP harmonization to correct the orientation of alleles. Additionally, we performed SNP harmonization to correct the orientation of alleles. The results showed that increased risk of T2D has a direct effect that decreased fracture risk (OR=0.974, 95%CI=0.953-0.995, P=0.017 adjusted BMI), and BMI mediated 9.03% of the protective effect. The multivariable MR analysis suggested that T2D also showed direct effect on increased BMD after adjusting for BMI (β=0.042, 95%CI=0.026-0.057, P=1.92×10-7). We didn’t observe the direct effect of MRI-derived visceral (β=0.02, P=0.831) and abdominal subcutaneous (β=0.03, P=0.57) on fracture risk adjusted for RSPO3 expression. We have updated the Methods and Results accordingly.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>The authors employed the Mendelian Randomization method to analyze the association between type 2 diabetes (T2D) and fracture using the UK Biobank data. They found that &quot;genetically predicted T2D was associated with higher BMD and lower risk of fracture&quot;. Additionally, they identified 10 loci that were associated with both T2D and fracture risk, with the SNP rs4580892 showing the highest signal. While the negative relationship between T2D and fracture has been previously observed, the discovery of these 10 loci adds an intriguing dimension to the findings, although the clinical implications remain uncertain.</p></disp-quote><p>Response: We appreciate the reviewer's thoughtful evaluation of our study. The hypothesis and idea of this study is that the genetically determined type 2 diabetes might not be associated with higher risk of fracture, but the risk association could be observed. However, when stratified by the risk factors secondary to the disease, we observed that the effect of T2D on the risk of fracture decreased when the number of risk factors secondary to T2D decreased, and the association became non-significant if the T2D patients carried none of the risk factors. These results suggested that the risk factors secondary to type 2 diabetes might contribute more to the risk of fracture. Therefore, the clinical implications of our study might lie in the health management of type 2 diabetes patients. We suggest that it is important to manage the complications of type 2 diabetes to prevent the risk of fracture.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations for the authors):</bold></p><list list-type="bullet"><list-item><p>Introduction/discussion: findings from MR previously published on that topic have not been discussed in this manuscript (eg, Mitchell et al, Diabetologia, 2021; Ahmad et al JBMR, 2016);</p></list-item></list></disp-quote><p>Response: In the manuscript, we discussed the previous MR findings from Trajanoska et al., BMJ, 2018. The study assessed the effect of 15 clinical risk factors (including type 2 diabetes) on fracture risk. Sorry that we missed the studies you mentioned, these two studies took BMD as the exposure, now we have included them in the paragraph where we discussed the effect of T2D on BMD (Page 14, Line 320-322).</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>In the one-sample MR analysis: I would suggest looking at whether the association between T2D GRS and fracture risk differ across fracture sites; in the hypothesis that BMI might be protective, performing the analysis separately for weight-bearing bones vs not weight-bearing bones would be interesting.</p></list-item></list></disp-quote><p>Response: According to your suggestion, we further categorized fractures into weight-bearing bones (neck, vertebrae, pelvic, femur, tibia) and other bones (detailed codes have been added to Supplementary Table 16). When we regressed the observed fracture on the wGRS, it indicated that there was trend of protective association between T2D wGRS and both weight-bearing bones fracture (OR=0.9772, 95%CI=0.9552-0.9997, P=0.04737, N of fracture=8,992) and other bones fracture (OR=0.9838, 95%CI=0.9688-0.9991, P=0.0386, N of fracture=20,317) (Figure 1). We have updated the Methods and Results accordingly (Page 6, line 129-134 and Page 18, line 408-412).</p><disp-quote content-type="editor-comment"><p>In this analysis, I would also suggest verifying the absence of sex interaction with T2D PRS on BMD and fracture risk</p></disp-quote><p>Response: Thanks for your suggestion, we further estimated the effect of sex interaction on BMD and fracture risk with T2D wGRS × sex interaction term in regression model. And you are right, we found no interactions (sex with T2D wGRS) on fracture risk (P=0.5576) and BMD (P=0.66). Moreover, we conducted the stratified analysis by sex. When we regressed the observed fracture on the wGRS in male, we found that the genetically determined type 2 diabetes was also associated with lower risk of fracture (OR=0.977, P=0.015) (adjusting for reference age, sex, BMI, physical activity, fall history, HbA1c and medication treatments). In female, the direction of the association remained with no significance (OR=0.986, P=0.139). We tested the heterogeneity between male and female, and found no significant difference (Pheterogeneity=0.457). Similarly, the genetically determined type 2 diabetes was associated with higher BMD in male (β=0.023, P=8.23×10-14) and female (β=0.022, P&lt;2.0×10-16), and Pheterogeneity=0.6306 (Supplementary Figure 2). We have updated the Methods and Results accordingly (Page 6, line 134-139 and Page 19, line 425-429).</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>In the two-sample MR analysis: I would suggest performing a multivariable MR to look at the effect of T2D adjusted for BMI on BMD and fracture risk (see Burgess et al, AJE, 2016)</p></list-item></list></disp-quote><p>Response: Thanks for your suggestion, in revision, the inverse weighted multivariable MR model was used to estimate the direct effect of T2D upon the fracture and BMD adjusted for BMI with ‘MVMR’ R package (<ext-link ext-link-type="uri" xlink:href="https://github.com/WSpiller/MVMR">https://github.com/WSpiller/MVMR</ext-link>). Specifically, we first extracted the overlapping SNPs from the summary data for T2D, BMI and fracture. Then the independent significant SNPs (P&lt;5×10−8 and R2&lt;0.1) for either T2D or BMI were pooled as instruments. Additionally, we performed SNP harmonization to correct the orientation of alleles. Additionally, we performed SNP harmonization to correct the orientation of alleles. The final IVs used in MVMR were presented in Supplementary Table 17. The results showed that increased risk of T2D has a direct effect that decreased fracture risk (OR=0.974, 95%CI=0.953-0.995, P=0.017 adjusted BMI) and increased BMD (β=0.042, 95%CI=0.026-0.057, P=1.92×10-7 adjusted BMI). We have updated the Methods and Results accordingly (Page 7, line 155-158, 162-164, and Page 20, line 456-465).</p><disp-quote content-type="editor-comment"><list list-type="bullet"><list-item><p>In the section &quot;infer the shared genetics&quot;. In addition of using waist circumference and waist-hip ratio, it would have been interesting to use GWAS summary statistics for subcutaneous and visceral adiposity (Agrawal, Nat Comm, 2022), and look at through multivariable MR whether RSPO3 mediate the effect of subcutaneous fat on fracture risk.</p></list-item></list></disp-quote><p>Response: Thanks for your suggestion, we downloaded the genetic summary data from Agrawal, Nat Comm, 2022, and performed the same SMR analysis as we did before. We found that higher expression of RSPO3 was associated with higher MRI-derived visceral (β=0.199, P=4.36×10-5). We have updated the Methods and Results accordingly (Page 9, line 206-208 and Page 22, line 494-495).</p><p>We didn’t observe the direct effect of MRI-derived visceral (β=0.02, P=0.831) and abdominal subcutaneous (β=0.03, P=0.57) on fracture risk adjusted for RSPO3 expression.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations for the authors):</bold></p><p>Specific comments</p><p>Several concerns regarding the study's concept and methodology should be addressed before accepting the findings as credible. I would like to invite the authors to comment on the following points.</p><p>(1) I find the authors' assertion that individuals with type 2 diabetes (T2D) exhibit both higher BMD and an increased risk of fracture to be unconvincing. The BMD measurement they refer to is based on areal BMD, which fails to account for the three-dimensional aspect of bone density. Existing evidence suggests that patients with T2D actually have lower trabecular bone scores (a predictor of fracture risk) compared to those without the condition. Furthermore, there is a lack of a clearly stated hypothesis underlying the study.</p></disp-quote><p>Response: Yes, in this study, the bone mineral density measurement is based on areal BMD. We made this clear in Abstract. And we agree that other measurements, such as trabecular bone score and chest CT texture analysis, could provide additional valuable information in the evaluation of fracture risk, especially in type 2 diabetes patients. We have discussed this in the manuscript (Page 13, line 295-300). Epidemiologic studies from the past decade provided evidence that increased bone fracture risk is one of the complications of type 2 diabetes. but the areal BMD in type 2 diabetes patients could be normal or even higher (Botella Martinez et al., 2016; Romero-Diaz et al., 2021).</p><p>In this study, we employed the mendelian randomization approach to investigate the relationship between type 2 diabetes and fracture/BMD, this method might facilitate the use of genetic data as instrumental variables to alleviate the bias of the unknown confounding factors. We found that the genetically predicted type 2 diabetes was associated with higher BMD and lower risk of fracture. That is to say, by alleviating the bias of the unknown confounding factors through MR analysis, the genetically predicted type 2 diabetes did not show bone paradox.</p><p>We then performed observational analysis in UK Biobank, and found that type 2 diabetes was associated with higher risk of fracture and increased BMD. Further, we stratified the T2D patients with five secondary risk factors (BMI≤25kg/m2, no physical activity, falls in the last year, HbA1c≥47.5mmol/mol and antidiabetic medication treatment), and found that the effect of type 2 diabetes on the risk of fracture decreased when the risk factors secondary to type 2 diabetes decreased, and the association became not significant if the type 2 diabetes patients carried none of the risk factors. That is to say, the diabetic bone paradox might not exist if the secondary risk factors of type 2 diabetes were eliminated.</p><p>The hypothesis and idea we want to deliver is that the genetically determined type 2 diabetes might not be associated with higher risk of fracture, but the association could be observed. However, when stratified by the risk factors secondary to the disease, we observed that the effect of T2D on the risk of fracture decreased when the number of risk factors secondary to T2D decreased, and the association became non-significant if the T2D patients carried none of the risk factors. These results suggested that the risk factors secondary to type 2 diabetes might contribute more to the risk of fracture. Therefore, it is important to manage the complications of type 2 diabetes to prevent the risk of fracture.</p><p>In addition, although we observed type 2 diabetes was observed to be associated with higher risk of fracture, but BMI mediated 30.2% of the protective effect. And the shared genetic architecture between type 2 diabetes and fracture suggested a top signal near RSPO3 gene. Higher expression of RSPO3 was associated with higher waist circumference and higher waist-hip ratio. These results suggested that relatively higher BMI in type 2 diabetes patients might benefit the higher BMD, as our previous study suggested that keeping moderate-high BMI (overweight) might be of benefit to old people in terms of fracture risk(Zhu et al., 2022).</p><disp-quote content-type="editor-comment"><p>(2) It is not a good idea to solely concentrate on overall fracture risk as it may obscure the potential relationship between T2D and specific fracture sites, such as hip and vertebral fractures. By solely considering total fracture incidence, important associations at individual fracture sites could be overlooked. I would like to propose that the authors expand their analysis to include the examination of hip and vertebral fractures. By incorporating these specific fracture types into their study, a more comprehensive understanding of the association between T2D and fractures can be achieved.</p></disp-quote><p>Response: This is a good suggestion, incorporating with the comments from another reviewer, and considering the sample size, we classified fractures into weight-bearing fractures (neck, vertebrae, pelvic, femur, tibia) and other bones (skull and facial, ribs, sternum, forearm, wrist and hand, foot and other unspecified body regions) fracture. We identified 6,582 (1.87%) participants with weight-bearing bones fracture and 9,586 (2.72%) participants with other bones fracture within the 352,879 UK Biobank participants. We observed a higher risk of fracture in the type 2 diabetes patients in the cox proportional hazards regression after adjusted for the reference age, sex, BMI, physical activity, fall history, HbA1c and medication treatments (weight-bearing bones fracture: HR=1.792, 95%CI 1.555-2.065, P=8.25×10-16; other bones fracture: HR=1.337, 95%CI 1.167-1.531, P=2.85×10−5), and additionally controlled for BMD (weight-bearing bones fracture: HR=1.850, 95%CI 1.602-2.136, P&lt;2×10−16; other bones fracture: HR=1.377, 95%CI 1.199-1.580, P=5.54×10−6). We have updated the manuscript according in Results, Methods and Figures (Page 11, line 245-250; Page 24, line 540-547; Figure 4A).</p><disp-quote content-type="editor-comment"><p>(3) I consider that there is an issue with combining data from both males and females in the analysis. It is widely recognized that women generally have a higher risk of fracture compared to men. Moreover, the association between BMD and fracture may vary between genders, and the risk of T2D is typically lower in women than in men. Therefore, I strongly recommend that the analysis be stratified by gender to account for these differences and provide a more accurate understanding of the relationships involved.</p></disp-quote><p>Response: Thanks for your suggestion, we now add the stratified results by sex to each analysis. Briefly, in wGRS analysis, we found that the genetically determined type 2 diabetes was associated with lower risk of fracture in male (OR=0.977, 95%CI=0.958-0.995, P=0.015) (adjusting for reference age, sex, BMI, physical activity, fall history, HbA1c and medication treatments). The association in female was not significant, but the direction is the same as the male (OR=0.986, 95%CI=0.969-1.004, P=0.139). Meanwhile, the genetically determined type 2 diabetes was associated with higher BMD in both male (β=0.023, 95%CI=0.017-0.030, P=8.23×10−14) and female (β=0.022, 95%CI=0.017-0.026, P&lt;2×10−16). In observational analysis, we observed a higher risk of fracture in the type 2 diabetes patients in the cox proportional hazards regression after adjusted for the reference age, sex, BMI, physical activity, fall history, HbA1c and medication treatments in male (HR=1.587, 95%CI 1.379-1.828, P=1.26×10−10) and female (HR=1.530, 95%CI 1.334-1.756, P=1.27×10−9), respectively. When we additionally controlled for BMD (HR=1.607, 95%CI 1.393-1.853, P=7.21×10−11 in male; HR=1.601, 95%CI 1.393-1.841, P=3.59×10−11 in female), we still observed increased risk of fracture in type 2 diabetes (Page 6, line 136-139; Page 11, line 241-243).</p><disp-quote content-type="editor-comment"><p>(4) My understanding is that &quot;BMD&quot; in UK Biobank refers to estimated BMD derived from ultrasound measurements, rather than being directly measured using dual-energy X-ray absorptiometry (DXA). It would be helpful to clarify whether the BMD mentioned in the manuscript refers to estimated BMD or DXA-based BMD to ensure accurate interpretation of the results.</p></disp-quote><p>Response: Yes, we used the BMD estimated from quantitative ultrasound measurement at heel as the outcome. Use of the device generates two variables, including speed of sound (SOS) and BUA (the slope between the attenuation of the sound signal and its frequency as it travels through the bone and soft tissue). Heel BMD was calculated by the following formula: BMD = 0.002592 ×(BUA+SOS)−3.687. We have made this clear in Methods (Page 23, line 526-530).</p><disp-quote content-type="editor-comment"><p>(5) The clarification regarding the nature of the 13,817 individuals with T2D mentioned in Supplementary Table 9 is needed. It is unclear whether this figure represents incidence or prevalence. If it refers to incidence, it would be informative to specify the duration of the follow-up period for these individuals.</p></disp-quote><p>Response: The UK Biobank data (application #41376), was applied in our study under a prospective design. We excluded participants if they were identified as follows: (1) ethnically identified as non-European (n = 30,481); (2) diagnosed as type 1 diabetes (n=4,455); (3) diagnosed with diseases associated with bone loss (n=21,560); (4) diagnosed as fracture with known primary diseases (n=7,222) (Supplementary Table 15). For the 439,982 UK biobank samples, we focused the participants diagnosed with T2D within the 10-year period from 1 January 2006 to 31 December 2015, leaving 425,772 participants (with 14,860 type 2 diabetes patients). Here, each type 2 diabetes patient had a diagnosis date (i.e., the reference date), we first calculated the onset age, then among the participants who were free of T2D, we selected up to 27 participants (whenever possible) whose age at the reference date (± 3 years) could be matching to the onset age as referents. In total, 363,884 non-T2D referents were individually matched with 6-year age band at the reference date. We prospectively followed these type 2 diabetes patients and referents from the reference date until diagnosis of fracture, death, emigration, 19 April 2021 (diagnose a fracture of the last person in the cohort), whichever came first (with the mean duration of type 2 diabetes 8.34 years). Survival time was calculated based on whether the patient had a fracture. If individuals had a fracture, the survival time is calculated as the time of the first diagnosis of fracture minus the reference date. If individuals did not have a fracture, it was defined as the minimum time of the reference date to diagnose a fracture of the last person in the cohort (19 April 2021), death, or emigration date. We excluded 25,865 participants with fracture diagnosis date, or death or emigration before the reference date, leaving 352,879 participants included in the final analysis (13,817 type 2 diabetes patients and 339,062 referents). We identified 16,147 (4.6%) participants with fracture within the 352,879 UK Biobank participant. We have made this clear in the Methods and Results (Page 18, line 400-406; Page 22-23, line 506-523; Page 10, line 231-233).</p><disp-quote content-type="editor-comment"><p>(6) I find the selection of participants for the analysis to be highly problematic. Supplementary Figure 1 suggests that individuals with a history of fracture were excluded from the study. However, it is well established that prior fracture history is a significant predictor of future fractures. Therefore, the exclusion of participants with prior fractures likely introduced selection bias into the analysis, potentially compromising the study's findings.</p></disp-quote><p>Response: Sorry that we used a misleading term “secondary fracture” in the manuscript and figure. What we want to say here is that “the participants diagnosed as fracture with known primary diseases” (n=7,222), because we want to investigate the effect of diabetes on fracture, we should exclude other factures with known reason. We have changed the term in the manuscript and figure accordingly (Page 18, line 405-406; Supplementary Figure 1).</p><p>Since this study is a prospective design, all the participants did not have fracture at the reference date, we prospectively followed these type 2 diabetes patients and referents from the reference date until diagnosis of fracture, death, emigration, 19 April 2021 (diagnose a fracture of the last person in the cohort), whichever came first. Therefore, each study subject either had one fracture or no fracture.</p><disp-quote content-type="editor-comment"><p>(7) It is unclear what exactly is meant by &quot;genetically predicted T2D.&quot; Could it possibly refer to the polygenic risk score derived from the variants associated with T2D? Clarification is needed regarding the methodology used to determine this &quot;genetically predicted T2D&quot; and its relation to the construction of a polygenic risk score based on T2D-associated variants.</p></disp-quote><p>Response: In this study, we used weighted genetic risk score (wGRS) method and two-sample Mendelian Randomization (MR) method to estimate the effect of genetically predicted T2D on fracture. We constructed the wGRS for the individuals in the UK biobank (294,571 samples with genotypes) as a linear combination of the selected SNPs weighted by their β coefficients on type 2 diabetes: wGRS = β1 ×SNP1 + β2 ×SNP2 + … + βn ×SNPn. n is the number of instrumental variables. To validate the wGRS results, we also performed the two-sample MR analyses that is independent of UK Biobank samples. We used three two-sample MR approaches, the inverse variance weighting (IVW), simple median and MR-PRESSO approaches. Both methods took the genetically predicted type 2 diabetes as the exposure (See Methods Page 18, line 419-422; Page 19, line 439-440).</p><disp-quote content-type="editor-comment"><p>(8) My understanding is that the Mendelian Randomization analysis relies on, among others, 2 assumptions: (1) the genetic marker is linked to the exposure (e.g., T2D), and (2) the genetic marker remains independent of the outcome (e.g., fracture) when considering the exposure and all confounding factors. In the authors' study, they identified 10 loci that exhibited associations with both T2D and fracture risk. This finding raises questions about whether the assumptions underlying Mendelian Randomization have been violated?</p></disp-quote><p>Response: You're absolutely right. Because the presence of horizontal pleiotropy could bias the MR estimates, we additionally used the MR pleiotropy residual sum and outlier (MR-PRESSO) method. When we excluded pleiotropic variants using restrictive MR-PRESSO method, the causal association was still detected between type 2 diabetes and fracture (OR=0.967, 95%CI=0.945-0.989, P=0.004) (Page 6, line 146-149).</p><disp-quote content-type="editor-comment"><p>(9) The analysis provided in Supplementary Table 10 appears to have certain limitations. From my understanding, the analysis treated fracture and BMD as outcome variables, with T2D regarded as the predictor variable. However, what is of interest is whether the association between T2D and fracture remains significant even after accounting for well-established risk factors for fractures, including BMD. It is crucial to determine whether the association between T2D and fracture is independent of these established risk factors. Therefore, I suggest the authors consider the following 3 models:</p><p>Model 1: fracture ~ age + T2D</p><p>Model 2: fracture ~ age + T2D + BMD</p><p>Model 3: fracture ~ age + T2D + BMD + fracture history + falls</p></disp-quote><p>Response: In our previous analysis, we have adjusted for 7 covariates (including fall history) in the basic model for fracture, i.e.</p><p>fracture ~ T2D + age + sex + BMI + physical activity + HbA1c + medication treatments + fall history (Model 0)</p><p>We have already included “fall history” in the basic model, according to your suggestion, we further considered an additional model for fracture by including BMD as the covariate:</p><p>fracture ~ T2D + age + sex + BMI + physical activity + HbA1c + medication treatments + fall history + BMD (Model 1)</p><p>We cannot include fracture history as the covariate because each study subject either had one fracture or no fracture, as we also answered in Question 6.</p><p>In model 0, we observed a higher risk of fracture in the type 2 diabetes patients in the cox proportional hazards regression after adjusted for the clinical risk factors including reference age, sex, BMI, physical activity, HbA1c, medication treatments and fall history (HR=1.527, 95%CI=1.385-1.685, P&lt;2.0×10-16). When we additionally controlled for BMD (model 1), we still observed increased risk of fracture in type 2 diabetes (model 1: HR=1.574, 95%CI=1.425-1.739, P&lt;2.0×10-16) (Supplementary Table 11).</p><p>We thank for your suggestion, and we have updated accordingly in Methods, Results, and Figures (Page 11, line 243-245; Page 24, line 539-540; Figure 4A).</p><disp-quote content-type="editor-comment"><p>(11) The dichotomization of data presented in Figure 4 is not considered ideal, as this approach often leads to a loss of valuable information. It is strongly recommended that the authors reconsider their data analysis strategy and reanalyze the data using continuous variables, such as BMI and HbA1c, to capture a more nuanced understanding of the relationships involved.</p></disp-quote><p>Response: We agree that dichotomization of data would lead to a loss of valuable information. In model 0 and model 1, we used the continuous variables in the analyses, we adjusted for the reference age, sex, BMI (as a continuous variable), physical activity, fall history, HbA1c (as a continuous variable) and medication treatments to analyze the relationship between type 2 diabetes and fracture in the cox proportional hazards regression. We have updated the Figure 4 accordingly.</p><p>In stratified analyses, we took 5 clinical factors secondary to the diseases to classify the individuals at risk, for example, if an individual had BMI≤25kg/m2, no physical activity, falls in the last year, HbA1c≥47.5mmol/mol and antidiabetic medication treatment, this individual was identified to have 5 risk factors, and so forth. Finally, 2,303 patients carried none of the risk factors, 4,128 patients accompanied with one of the risk factors, and 4,252 patients carried at least two risk factors. We found that the effect of type 2 diabetes on the risk of fracture decreased when the risk factors secondary to type 2 diabetes decreased. We have made this clearer in the Methods and Results (Page 11, line 255-257; Page 24, line 548-552).</p><disp-quote content-type="editor-comment"><p>(12) The conclusion of the study appears to be somewhat confusing. In the Abstract, the authors initially state that &quot;genetically predicted T2D was associated with higher BMD and lower risk of fracture.&quot; However, later on, they write that &quot;the genetically determined T2D might not be associated with a higher risk of fracture.&quot; This discrepancy raises uncertainty about the clear take-home message of the study.</p></disp-quote><p>Response: Here we just want to deliver the same message by different statements, avoiding the repeat of writing. The take-home message we want to deliver is that the genetically determined type 2 diabetes might not be associated with higher risk of fracture, but the association could be observed, suggesting the risk factors secondary to type 2 diabetes might contribute more to the risk of fracture. Therefore, it is important to manage the complications of type 2 diabetes to prevent the risk of fracture, especially the 5 factors we investigated in this study.</p><disp-quote content-type="editor-comment"><p>(13) Apologies if I offend It seems that the authors lack comprehensive knowledge of the osteoporosis literature. In the Introduction, their definition of osteoporosis as &quot;an age-related common disease characterized by low bone mass&quot; is inadequate. It would be advisable for the authors to provide a more widely accepted and standard definition of osteoporosis to ensure accuracy and alignment with established definitions in the field.</p></disp-quote><p>Response: Thanks for your suggestion. Now we changed the statement as follow “Osteoporosis is a common chronic disease characterized by low bone mass and disruption of bone microarchitecture. Fragility fracture is the ultimate outcome of poor bone health”.</p><disp-quote content-type="editor-comment"><p>(14) There are several instances in which the authors use non-standard terminologies. For example, the use of the word 'effects' (in &quot;the observed effect of T2D on fracture risk&quot;) is inappropriate since this study is observational in nature.</p></disp-quote><p>Response: In statistics, an effect size is a value measuring the strength of the relationship between two variables in a population. We have changed some of the words “effect” into “effect size” (whenever appropriate) to refer the Hazard ratio between T2D on fracture.</p><disp-quote content-type="editor-comment"><p>(15) Please provide a reference for &quot;diabetic bone paradox&quot;.</p></disp-quote><p>Response: We have cited Botella Martínez et al, Endocrinol Nutr. 2016 and Romero-Díaz et al, Diabetes Ther. 2021 in both Introduction and Discussion (Page 3, line 76-77; Page 13, line 295-297).</p><p>References</p><p>Botella Martinez S, Varo Cenarruzabeitia N, Escalada San Martin J, Calleja Canelas A. The diabetic paradox: Bone mineral density and fracture in type 2 diabetes. Endocrinol Nutr. 2016, 63: 495-501.</p><p>Romero-Diaz C, Duarte-Montero D, Gutierrez-Romero SA, Mendivil CO. Diabetes and bone fragility. Diabetes Ther. 2021, 12: 71-86.</p><p>Zhu XW, Liu KQ, Yuan CD et al. General and abdominal obesity operate differently as influencing factors of fracture risk in old adults. iScience. 2022, 25: 104466.</p></body></sub-article></article>